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ABSTRACT 
 
Synaptic plasticity – the ability of a synapse to change – is fundamental to basic 
brain function and behavioral adaptation. Studying the mechanisms of synaptic plasticity 
benefits our understanding of the formation of neuronal connections and circuitry, which 
has great implications in the field of learning and memory and the studies of numerous 
human diseases.  
The Drosophila larval neuromuscular junction (NMJ) system is a powerful system 
for studying synaptic plasticity. The NMJ consists of at least two different types of 
motorneurons innervating the body wall muscles. Type I motorneurons controls muscle 
contraction using glutamate as the neurotransmitter, while type II are modulatory 
neurons that contain octopamine. Octopamine is a potent modulator of behavior in 
invertebrates. Nevertheless, its function at the synapse is poorly understood.  
In my thesis research, I investigated the role of octopamine in synaptic plasticity 
using the Drosophila NMJ system. Preliminary observations indicate that increased 
larval locomotion during starvation results in an increase of filopodia-like structures at 
type II terminals. These structures, which we termed as “synaptopods” in our previous 
studies, contain synaptic proteins and can mature into type II synapses. I demonstrated 
that this outgrowth of type II terminals is dependent on activity and octopamine. 
Mutations and genetic manipulations affecting the production of octopamine decrease 
synaptopods, whereas increase of type II activity or exogenous application of 
octopamine increase synaptopods. Interestingly, I found that the type II octopaminergic 
neurons have an absolute dependence on activity for their innervation of the muscles. 
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Blocking activity in these neurons throughout development results in no type II synapses 
at the NMJ, whereas blocking activity after the formation of synapses results in gradual 
degradation of type II terminals.  
Next, I examined the autoregulatory mechanism underlying the octopamine-
induced synaptic growth in octopaminergic neurons. I discovered that this positive-
feedback mechanism depends on an octopamine autoreceptor, Octß2R. This receptor in 
turn activates a cAMP- and CREB-dependent pathway that is required in the 
octopamine-induction of synaptopods. Furthermore, I demonstrated that this 
octopaminergic autoregulatory mechanism is necessary for the larva to properly 
increase its locomotor activity during starvation.  
Thirdly, I investigated the possibility that type II innervation might regulate type I 
synaptic growth through octopamine. We found that ablation, blocking of type II activity, 
or the absence of octopamine results in reduced type I outgrowth, and this paracrine 
signaling is mediated by Octß2R which is also present in type I motorneurons. 
Lastly, the function of another octopamine receptor, Octß1R, was examined. In 
contrast to Octß2R, Octß1R is inhibitory to synaptic growth. I demonstrated that the 
inhibitory effect of this receptor is likely accomplished through the inhibitory G-protein 
Goα. Similar to Octß2R, Octß1R also regulates the synaptic growth of both type I and 
type II motorneurons in a cell-autonomous manner. The inhibitory function of this 
receptor potentially breaks the positive feedback loop mediated by Octß2R, allowing the 
animal to reset its neurons when the environment is favorable.  
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In summary, the research presented in this thesis has unraveled both 
autoregulatory and paracrine mechanisms in which octopamine modulates synaptic and 
behavior plasticity through excitatory and inhibitory receptors. 
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The human brain is comprised of over one hundred billion neurons, making 
countless synapses. These synaptic connections allow communication between 
neurons, which are crucial to brain function. Synapses are dynamically changing 
throughout a person’s lifetime (Kandel et al., 2000). This process, which is called 
synaptic plasticity, refers to the ability of neurons to undergo changes in response to 
external factors or internal factors (Griffith and Budnik, 2006). Synaptic plasticity 
constitutes the basis of neuronal circuitry formation during development. It allows 
flexibility and variation in the circuitry, depending on the organism’s experiences. 
Therefore, even genetically identical organisms can vary in developmental patterns and 
behaviors. The goal of this doctoral thesis was to study the molecular mechanisms of 
synaptic plasticity regulated by the biogenic amine, octopamine, using molecular genetic 
strategies in the fruit fly Drosophila melanogaster.  
Until the twentieth century, the general dogma was that the brain is a relatively 
fixed structure after passing a critical period during early childhood. However, this belief 
was later challenged by discoveries of plasticity in the central nervous system, including 
those of Santiago Ramón y Cajal, revealing that many aspects of the brain remain 
plastic even into adulthood (Rakic, 2002). Learning is the acquisition of new knowledge 
and skills. For us to successfully learn or memorize, certain changes must occur in the 
brain to represent the new knowledge or skills. These changes include formation of new 
synapses and strengthening of existing synapses. The capacity of the brain to change 
with learning is plasticity (Black et al., 1997). In fact, many genes that affect learning and 
memory also affect synaptic growth. For instance, in Drosophila, learning mutants like 
dunce (phosphodiesterase) and rutabaga (adenylate cyclase) have been shown to have 
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altered number of synapses or synaptic strength (these mutants will be discussed 
below) (Zhong et al., 1991; Zhong et al., 1992; Davis et al., 2005). Therefore, studying 
synaptic plasticity can potentially facilitate our understanding of the mechanisms of 
learning and memory. Moreover, synaptic plasticity also plays an important role in 
numerous human diseases. For instance, in the case of a stroke where many neurons 
are damaged or destroyed, it is believed that the recovery process requires a significant 
amount of plasticity such that new functions can be assigned to the uninjured neurons 
(Cheetham and Finnerty, 2007; Kleim and Jones, 2008). In the case of Alzheimer’s 
disease, apart from the hallmarks of plaque accumulation and neuronal loss, synaptic 
loss in the hippocampus and neocortex is also a common phenomenon (Palop et al., 
2006). Interestingly, these are the most plastic regions of the brain. Loss of synaptic 
plasticity in these regions may contribute to the cognitive deficits commonly seen in 
Alzheimer’s patients. In other words, Alzheimer’s disease can be considered to be a 
disorder of synapses (Selkoe, 2002). Furthermore, physical therapies such as 
sensorimotor retraining activities and proprioceptive stimulation that involve specific 
fingers motion program have been shown to stimulate plasticity and alleviate focal 
dystonia (Candia et al., 2003), which commonly develops in Alzheimer’s patients. In 
summary, since plasticity plays a role in learning and memory and a number of human 
diseases, it is of utmost importance for us to study its mechanisms.  
 
The Role of Synaptic Plasticity in Behavioral Adaptation and Survival 
Since synaptic plasticity is critical in learning and memory, it greatly contributes to 
an animal’s adaptation to the ever-changing environment. Studies have shown that 
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environmental changes could alter behavior by modifying existing synapses between 
neurons and by neurogenesis in the hippocampus and other parts of the brain (Rampon 
and Tsien, 2000; Ponti et al., 2008). For example, enriched environments have been 
shown to induce more basal dendrites of neurons in the visual cortex (Holloway, 1966) 
and higher synapse density in the CA3 hippocampal region (Altschuler, 1979) of mice. 
At the same time, these enrichments also leads to better performances in rodents’ 
learning tasks such as the Hebb-Williams maze (Ravizza and Hershberger, 1966) and 
Morris water maze (Mohammed et al., 1990). Even in simple organisms like the fruit fly 
Drosophila melanogaster, experiences can still sculpt the synapses at both the structural 
and functional level. For example, rearing larvae at a higher temperature results in more 
synaptic growth at the larval neuromuscular junction (NMJ) (Sigrist et al., 2003), and 
locomotor increase during food-deprivation results in larger synaptic vesicles at the NMJ 
(Steinert et al., 2006). The experience-molded nervous system can in turn monitor 
behavioral changes according to the need of the animal, allowing adaptation to the 
environment and benefiting survival. It is believed that this kind of behavioral plasticity is 
a key factor which has been rigorously selected for in the evolution of organisms, where 
the loss of such flexibility in behavior to adapt may render a species extinct (Hazlett 
1988).  
 
Biogenic Amines Regulate Synaptic and Behavioral Plasticity 
 One of the most conserved methods of facilitating synaptic and behavioral 
changes in both vertebrates and invertebrates is the use of biogenic amines. Perhaps 
arguably the most prominent series of studies on this subject belong to Nobel Prize 
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laureate, Eric Kandel, and his studies on the gill-withdrawal reflex of the marine mollusk 
Aplysia. Kandel examined three forms of learning in Aplysia (habituation, sensitization, 
and classical conditioning) (Pinsker et al., 1970, 1973; Carew et al., 1972, 1981). The 
study of habituation was performed by repeatedly evoking the gill-withdrawal reflex 
using a light tactile stimulus to the siphon or mantle shelf of the animal. It was found that 
the amplitude of the gill-withdrawal response showed marked decrement (Pinsker et al., 
1970). Sensitization was performed by presenting a noxious stimulus such as electrical 
shock to the head or tail of the animal, inducing a massive gill-withdrawal reflex. Animals 
with shock experiences enhance its defensive response by increasing its duration of gill-
withdrawal when the same stimulus is presented again (Pinsker et al., 1973). In classical 
conditioning, the light tactile stimulus is paired with electrical shock for training. The 
trained animal then associates the light tactile stimulus to danger, and would respond 
with a stronger and longer gill-withdrawal reflex (Carew et al., 1981). By studying these 
different forms of learning in Aplysia, two stages of memory storage was observed in the 
gill-withdrawal reflex – short-term and long-term facilitation. Short-term facilitation stems 
from changes in synaptic strength between neurons (Castellucci et al., 1970), while the 
conversion of short-term to long-term facilitation requires the formation of new 
connections and protein synthesis (Castellucci et al., 1989). In studying the molecular 
mechanisms of short and long-term facilitation, Kandel and colleagues discovered that 
the biogenic amine serotonin plays an important role in both forms of memory. Serotonin 
is normally released in vivo by interneurons in Aplysia by stimulation of the tail. It was 
found that a single pulse of serotonin produces a transient enhancement of synaptic 
strength independent of protein synthesis, whereas five pulses produce long-term 
facilitation that could be blocked by protein- and RNA-synthesis inhibitors (Abel and 
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Kandel, 1998). Serotonin was found to increase cyclic adenosine monophosphate 
(cAMP) in sensory neurons (Ocorr and Byrne, 1985). cAMP has been shown to be an 
important second messenger in presynaptic facilitation via activation of Protein Kinase A 
(PKA). It was found that injection of cAMP, PKA or bath application of forskolin produces 
the similar facilitation as that produced by serotonin (Brunelli et al., 1976; Castellucci et 
al., 1980; Klein 1993). Moreover, in cell-free membrane patches from Aplysia sensory 
neurons, the purified catalytic subunit of PKA reduces the number of opened S-type K+ 
channel, simulating most aspects of the action of serotonin (Shuster et al., 1985). This 
enhances membrane excitability, and contributed to short-term facilitation. On the other 
hand, experiments using fluorescent ratio imaging to track the catalytic subunit of PKA 
showed that PKA translocates to the nucleus in sensory neurons in response to multiple 
pulses of serotonin (Bacskai et al., 1993). PKA then phosphorylates cAMP response 
element binding protein (CREB), triggering the transcription of synaptic effector proteins. 
The synthesis of new proteins is necessary for long-term facilitation, which involves the 
formation of new synapses and the strengthening of existing synapses (Byrne and 
Kandel, 1996; Abel and Kandel 1998).  
Apart from serotonin, the mammalian catecholamines, adrenaline (epinephrine) 
and noradrenaline (norepinephrine), are also key regulators of synaptic and behavioral 
plasticity. Adrenergic receptors are metabotropic G-protein-coupled receptors (GPCRs). 
There are two main groups of adrenergic receptors – α and β. α1-adrenergic receptors 
are Gq-coupled, and are capable of increasing intracellular Ca2+ through the 
phospholipase C pathway (Gibbs and Bowser 2010). α2-receptors are Gi-coupled and 
are inhibitory to the cAMP pathway (Ma et al., 2005). The β-receptors, including β1, β2 
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and β3, are in general Gs-coupled and increase cAMP and adenylate cyclase activity 
(with the exception that β2 is also Gi-coupled and can be inhibitory) (Xiao, 2001). Both 
adrenaline and noradrenaline are well-studied stress hormones responsible for the “fight 
or flight” effect in vertebrates. Noradrenaline increases heart rate, triggers the release of 
glucose from energy stores, suppresses immunity and even potentially mobilizes the 
release of lipids from mammalian adipocytes, presumably to provide a temporary source 
of energy for the animal to evade a dire situation (Roeder, 2005). In terms of synaptic 
plasticity, noradrenaline is involved in the retrieval of contextual memories (Murchison et 
al., 2004). In this study, mice were trained to associate footshock with both a tone (cue) 
and an apparatus (context) in a single training trial. Then either the cue or the context is 
given to the mice. Wild-type mice freeze upon exposure to either conditioned stimulus, 
while mice lacking noradrenaline exhibit normal cued memory but impaired contextual 
fear memory (Murchison et al., 2004). In contrast, mice injected with adrenaline showed 
enhanced contextual memory (Frankland et al., 2004). Noradrenaline has also been 
implicated to play a role in long-term potentiation (LTP). LTP is believed to be a cellular 
model for memory formation. When high frequency stimulation is performed on a 
presynaptic neuron, a significant increase in the postsynaptic response is produced 
(Sarvey et al., 1989; Bliss and Lomo, 1973). In hippocampal slices, perfusion of 
noradrenaline enhances the magnitude of LTP by approximately 50% (Hu et al., 2007). 
It has also been demonstrated by western blots from hippocampal slices that 
noradrenaline induces phosphorylation of the GluR1 subunit of the AMPA receptor. This 
in turn facilitates its delivery to the synapse, as demonstrated by a GFP-tagged GluR1 
(Hu et al., 2007). This phosphorylation was likely mediated by PKA as it was abolished 
by PKA inhibitors. Injection of adrenaline in vivo also increases the phosphorylation of 
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GluR1 in hippocampal lysates (Hu et al., 2007). Adrenergic signaling is also involved in 
long-term depression (LTD). LTD is induced by a long duration of low frequency 
stimulations, resulting in decreased postsynaptic response (Ito et al., 1982). LTD can be 
induced in hippocampus slice preparations of rats subjected to hemorrhage (removal of 
25% blood volume). Injection of α2-adrenoreceptor inhibitors blocked this LTD in 
hemorrhaged rats, whereas bath application of noradrenaline induces LTD in the 
hippocampi of normal rats (Kuzmiski et al., 2007).  
 In the fruit fly Drosophila melanogaster, dopamine and octopamine have been 
rigorously studied for their roles in learning and memory (Davis, 2005). Dopamine and 
octopamine receptors are also regulators of cellular cAMP levels, and the cAMP 
signaling pathway has been demonstrated to be critical for classical conditioning 
(Dubnau and Tully, 1998). In fruit flies, the Rutabaga gene encodes a major adenylate 
cyclase, responsible for cAMP production; whereas Dunce encodes a cAMP-specific 
phosphodiesterase, responsible for reduction of cAMP. Both rutabaga and dunce 
mutants are defective in learning (Davis, 2005). Other key molecules in the cAMP 
pathway like PKA and CREB are also involved in learning and memory. Expression of 
an inhibitory form of the regulatory subunit of PKA or a dominant negative form of CREB 
impairs long-term memory (Abel et al., 1997; Yin et al., 1994). Since dopamine and 
octopamine are important regulators of cAMP signaling. It is believed that these 
molecules are responsible for reinforcing the unconditioned stimulus in classical 
condition (Davis, 2005). Blocking of dopaminergic neurons during conditioning but not 
retrieval abolishes aversive memory (pairing shock with odor), whereas mutants lacking 
9 
 
  
octopamine are defective in appetitive memory (pairing sugar reward with odor) 
(Schwaerzel et al., 2003).  
 Tyramine, the precursor of octopamine, was original thought to be just a transient 
molecule in the process of octopamine biosynthesis. Although in recent years, studies 
have demonstrated that it can function independently from octopamine and act as a 
neurotransmitter in Caenorhabditis elegans (C. elegans), modulating egg-laying, 
reversal and head oscillation behaviors (Alkema et al., 2005). The role of this biogenic 
amine in synaptic and behavioral plasticity is just beginning to be examined.  
 
Octopamine: A Powerful Ruler of Invertebrate Behavior 
Octopamine, originally discovered in the octopus, is the invertebrate counterpart 
of mammalian adrenaline or noradrenaline. Its chemical structure is similar to these 
catecholamines as well as its precursor, tyramine (Fig. 1-1). In invertebrates, 
octopamine is a major neurotransmitter, neuromodulator and neurohormone. It is a very 
potent, multifunctional molecule that regulates many types of behavior and mediates 
diverse physiological processes in both the peripheral and central nervous systems 
(Roeder, 2005). Octopamine is the neurotransmitter for light production in the firefly 
lantern (Robertson and Carlson, 1976). In lobsters, injection of octopamine into the 
circulatory system results in the displaying of submissive postures (Livingstone et al., 
1980), whereas in crayfish octopamine induces escape behavior (Glanzman and 
Krasne, 1983). Octopamine injection into the house cricket Acheta domesticus results in 
elevation of carbohydrate and fatty acid in the hemolymph (Fields and Woodring, 1991), 
and this elevation of lipid and sugar by octopamine involves cAMP production and can 
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be blocked by the α-adrenergic antagonist phentolamine (Fields and Woodring, 1991). 
In the blowfly Phormia regina, injection of octopamine induces hyperphagia. Blowflies 
injected with octopamine imbibe significantly more sucrose solution than control 
animals, and their body weight is at least doubled (Long and Murdock, 1983). In the 
honeybee Apis mellifera, injection of octopamine can be used as a substitution for 
sucrose reward in classical conditioning (Hammer and Menzel, 1998).  In C. elegans, 
octopamine inhibits pharyngeal pumping by affecting the duration of pharyngeal muscle 
action potentials (Horvitz et al., 1982). Incubation of C. elegans with octopamine 
suppresses serotonin-dependent aversive behavior (Wragg et al., 2007). Octopamine 
also mediates CREB activity during starvation in C. elegans. CREB activity was 
monitored using a GFP reporter. Starvation induces an increase of GFP signal in control 
animals but not in octopamine receptor mutants (Suo et al., 2006). 
Many advances were made in the study on the physiological changes mediated 
by octopamine using the locust Schistocerca gregaria, due to its large, easily accessible 
muscles which are ideal for electrophysiology. Numerous studies suggest that 
octopamine has excitatory modulatory functions in specific skeletal and visceral muscles 
and increases the efficiency of both muscle contraction and relaxation. Bath application 
of octopamine results in the enhancement of amplitude and speed of evoked 
contractions of muscles, followed by quicker relaxation (Whim & Evans, 1988; Orchard 
and Lange, 1985; Braunig et al., 1994). Octopamine levels in the locust hemolymph are 
raised during locomotor activity (Goosey and Candy 1980) and can be doubled under 
stressful starvation conditions (Davenport and Evans, 1984). This increase of 
octopamine remains in the hemolymph for approximately 4 hrs even after the starved 
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animals have been re-fed. It has been postulated that octopamine may temporarily 
increase the availability of carbohydrates and lipid substrates in the hemolymph, 
allowing a starved animal to increase its locomotor activity for food-seeking (Evans, 
1985). 
In fruit flies, octopamine is required for normal egg-laying in adult females 
(Monastirioti et al, 1996). Mutant female flies devoid of tyramine-ß-hydroxylase (TBH), 
the enzyme for biosynthesis of octopamine, retain their eggs in their oviduct. This egg-
laying defect can be rescued by either feeding the flies with octopamine or expressing 
TBH in the oviduct, suggesting octopamine’s modulatory role in oviductal muscle 
contraction. In adult males, octopamine is involved in courtship and aggressive behavior 
(Certel et al., 2007; Hoyer et al., 2008; Zhou et al., 2008). Octopamine is necessary for 
normal locomotor activity of both larvae and adult flies (Saraswati et al., 2003; Hardie et 
al., 2007). Octopamine is also involved in sleep-wake behavior via the activation of PKA 
(Crocker and Sehgal, 2008). Flies devoid of octopamine have increased sleep that is 
rescued by feeding with octopamine, whereas flies with hyperexcitable octopaminergic 
neurons have decreased sleep that can be suppressed with decreased PKA activity 
(Crocker and Sehgal, 2008). In terms of learning and memory, octopamine has been 
shown to be critical in appetitive memory in adult flies (Schwaerzel et al., 2003) and 
larvae (Schroll et al., 2006). Notably, in adult flies, this form of octopamine-dependent 
conditioning produces long-term memory much more readily than aversive memory 
which does not involve octopamine (Krashes et al., 2008). In aversive conditioning, five 
sessions of spaced training are required to induce long-term memory (Tully et al., 1994). 
In contrast, a single session of appetitive memory training produces long-term memory 
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(Krashes et al., 2008). Similar to aversive long-term memory, this appetitive long-term 
memory is also cAMP and protein synthesis dependent, as the expression of a dominant 
negative CREB or the feeding of protein synthesis inhibitor abolished it (Krashes et al., 
2008).  
 
Octopamine Receptors are Modulators of Synaptic and Behavioral Plasticity 
 Octopamine receptors are G-protein-coupled receptors (GPCRs) resembling 
adrenergic receptors, capable of increasing Ca2+ or modulating cAMP levels (Balfanz et 
al., 2005; Evans and Maqueira, 2005). There are a total of four octopamine receptors 
identified in the Drosophila genome – OAMB, Octß1R (OA2), Octß2R and Octß3R. 
OAMB shares amino acid sequence homology with α-adrenergic receptors, and is 
capable of increasing intracellular Ca2+ and cAMP (Han et al., 1998). It has high 
expression levels in the mushroom bodies, which are the center of learning and memory 
in fruit flies (Han et al., 1998). OAMB is necessary for normal ovulation via Ca2+ 
signaling (Lee et al., 2009) and sleep-wake behavior via cAMP (Crocker et al., 2010). 
However, it has been suggested that the activation of cAMP level by OAMB is relatively 
low. The remaining octopamine receptors that resemble ß-adrenergic receptors may 
elicit a much stronger cAMP activation response, placing them as potential modulators 
of synaptic and behavioral plasticity as well (Balfanz et al., 2005; Evans and Maqueira, 
2005). Nevertheless, where these Octß receptors are expressed in Drosophila and how 
they function in vivo are largely unknown. Furthermore, despite the vast amounts of 
behavioral studies involving octopamine and its receptors performed in the past few 
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decades, the role of octopaminergic signaling in synaptic plasticity is still very poorly 
understood. 
 
The Drosophila Larval Neuromuscular Junction (NMJ) as a Model System to Study 
Octopaminergic Control of Synaptic Plasticity 
Despite our primary interest in the brain, it is relatively difficult to manipulate and 
visualize specific neurons and synapses without inflicting damage to it, partly due to the 
vast complexity of circuitries present. Brain slices and cultured neuronal preparations 
offer better accessibility and resolution, but they still raise the question of relevance in 
vivo.  
The Drosophila larval neuromuscular junction (NMJ) is a powerful model system 
that has been used for decades for studying synaptic plasticity. The post-synaptic body 
wall muscles of the larva are arranged in a segmentally repeated manner. The muscles 
are innervated by the pre-synaptic motorneurons, whose cell bodies reside in the ventral 
ganglion, and project their axons to the NMJ to control muscle activities. During its 
development from first to third instar larval stages, the animal dramatically increases in 
size. The number of muscles does not increase, but the size of muscles can increase up 
to a hundred fold (Fig. 1-2). In order to maintain synaptic efficacy, motorneurons 
undergo continuous addition of varicosities called “boutons”, which are the sites of 
neurotransmitter release (Jan and Jan, 1976). This kind of synaptic plasticity is activity-
dependent. Genetic increase of presynaptic activity using ion channel mutations results 
in significant increase of synaptic outgrowth at the NMJ (Budnik et al., 1990). Food-
deprivation-induced increase of locomotor activity also increases presynaptic release. 
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Although, no structural changes were noted, possibly due to the short time scale 
(Steinert et al., 2006). Furthermore, NMJs are highly tractable and the synapses are 
easily quantifiable and accessible by electrophysiology. Thus, comparisons of the same 
NMJ can be easily performed across different animals. In addition, Drosophila has a 
relatively short life cycle of about ten days, allowing genetic manipulation within a short 
period of time. Genetic tools are often readily available in the Drosophila community, 
partially due to the well-establish Gal4/UAS bipartite driver/promoter system (Duffy, 
2002), as well as the availability of mutants from forward genetic screens and multiple 
transgenic RNAi collections. Taken together, the larval NMJ is a prime system for 
studying the mechanisms of synaptic plasticity. 
 The larval NMJ contains at least four different types of motorneurons (Johansen 
et al., 1989; Budnik and Ruiz-Canada, 2006). Type Ib (type I big) and type Is (type I 
small) motorneurons innervate the body wall muscles with large synaptic boutons (~2-3 
µm). Type I boutons are the most abundant class of boutons at the NMJ. They release 
glutamate, which is the major neurotransmitter at the NMJ. Type I innervate all 30 
muscles per segment in approximately one neuron to one muscle ratio, and responsible 
for controlling individual muscle contractions. Type II and type III motorneurons are 
modulatory neurons. Type II contains octopamine (Monastirioti et al., 1995) and type III 
contains a variety of peptides (Cantera and Nassel, 1992; Gorczyca et al., 1993).  
Comparing to type I, type II motorneurons innervate the body wall muscles in the form of 
smaller synaptic boutons (~1 µm) (Fig. 1-3). They originate from only a small number of 
cell bodies in the ventral ganglion, but innervate almost the entire muscle field (see 
below) (Monastirioti et al., 1995). Thus, when these neurons fire, virtually the entire 
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muscle field would be affected. This architecture strongly suggests them as modulatory 
neurons that exert global regulation over most of the NMJs (Budnik and Ruiz-Canada, 
2006). Since the NMJ system contains both glutamatergic type I and octopaminergic 
type II motorneurons neighboring to each other, and since the system gives us great 
resolution in visualization and access to these neurons independently, it is the ideal 
system for studying octopaminergic modulation of synaptic plasticity.  
 
The Anatomy Octopaminergic Type II Motorneurons 
 There are three type II motorneurons per segment in the ventral ganglion. Each 
triplet of these ventral unpaired neurons extends axons towards the dorsal side, 
combines into one bundle and then bifurcates laterally, exiting the ventral ganglion in 2 
separate nerves bilaterally (Fig. 1-4). Each of these nerves appears to contain 3 axons 
(Fig. 1-5) which lead to the corresponding hemisegment (half segment) of body wall 
muscles (Fig. 1-2). The 3 axons from each lateral nerve innervate approximately 23 out 
of 30 body wall muscles per hemisegment, with the exception of muscle 3 to 7, 25 and 
28 (Monastirioti et al., 1995) (Fig. 1-6). Thus, 3 type II motorneurons per segment in the 
ventral ganglion innervate approximately 46 muscles per segment of the body wall. 
Notably, most muscles devoid of type II innervation are ventral interior muscles that are 
located near internal organs. It is possible that this architecture prevents high 
concentrations of octopamine secretion from affecting the functions of internal organs, 
which could be undesirable.  
 Tdc2-Gal4 is a driver fly line generated by fusing the promoter region of the 
tyrosine decarboxylase-2 (Tdc2) gene to Gal4 transcription factor (Cole et al., 2005). 
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Since Tdc2 is the enzyme responsible for the biosynthesis of tyramine (precursor of 
octopamine) (Fig. S2-3A), this driver line expresses Gal4 in all tyraminergic and 
octopaminergic neurons in the central nervous system (CNS). We found that this line 
labels all type II motorneurons at the NMJ (Fig. 1-3). Furthermore, all type II 
motorneurons contain tyramine-ß-hydroxylase (TBH), the enzyme for converting 
tyramine into octopamine (Fig. S2-3A), as indicated by anti-TBH immunostaining (Fig. 
S2-3B). Thus, Tdc2-Gal4 allows us to manipulate all octopaminergic type II 
motorneurons at the larval NMJ. 
 
Uncovering the Mechanism of Octopaminergic Signaling and Its Impacts 
My thesis research focused on the role of octopamine in synaptic plasticity at the 
Drosophila larval NMJ and larval behavioral plasticity in response to food-deprivation.  
In the second chapter of my thesis, I will present compelling evidence that 
octopamine induces synaptic growth at its own type II octopaminergic arbors 
(autoregulatory signaling). I discovered that this positive feedback mechanism requires 
Octß2R receptor, which activates a cAMP- and CREB-dependent pathway. Notably, this 
autoregulation was necessary for the increase of larval locomotor activity during 
starvation, suggesting its importance to survival. Furthermore, octopamine also induces 
synaptic growth at neighboring type I glutamatergic terminals through the same receptor 
Octß2R present in type I motorneurons (paracrine signaling). Octopamine also 
increases synaptic strength in type I motorneurons in an Octß2R-dependent manner, 
strongly suggesting type II as modulatory neurons regulating global synaptic plasticity. In 
addition, I made the surprising discovery that the type II innervation of body wall 
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muscles requires activity. This absolute requirement for electrical activity for type II 
synaptogenesis is in contrast to the common belief that activity is only important for 
refinement of existing connections.  
In the third chapter of my thesis, I will present an interesting finding that another 
octopamine receptor, Octß1R, functions in complete opposition to Octß2R which we 
described chapter 2. Octß1R, which is also present in both type I and II motorneurons, 
inhibits synaptic growth. My data strongly suggests that this is achieved via the inhibitory 
G-protein, Goα, which inhibits cAMP production. Intriguingly, the disruption in Octß1R 
results in near-saturation levels of cAMP and promotes synaptic outgrowth. This in turn 
blocks the octopamine-induced excitatory signals via Octß2R, resulting in no further 
synaptic outgrowth in type II arbors in response to octopamine. As a consequence of 
this loss of synaptic plasticity in the octopaminergic neurons, the starvation-induced 
locomotor increase was abolished. This loss of behavioral plasticity due to blockage of 
octopamine autoregulatory signals confirmed our findings in the previous chapter, and 
further emphasized the importance of plasticity in aminergic neurons.  
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Figure 1-1. The chemical structure of octopamine and related biogenic amines. 
Tyramine is the precursor of octopamine. Octopamine shares similarities in structure 
and function with mammalian noradrenaline (norepinephrine) and adrenaline 
(epinephrine). Dopamine is the precursor of noradrenaline and adrenaline. Both 
tyramine and dopamine are derived from the amino acid tyrosine. 
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Figure 1-2 
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Figure 1-2. (Adapted from Budnik and Ruiz-Canada, 2006) Body wall muscles of the 
Drosophila larva. Third star wandering stage (left) and first instar (right) larval body wall 
muscles preparations labeled with FITC-conjugated phalloidin. During development, the 
number of muscles does not increase, but the size of each muscle can increase up to 
100 fold. Abdominal segments 1-7 are labeled as A1 to A7. Up is anterior. 
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Figure 1-3 
 
 
23 
 
  
Figure 1-3. (Adapted from Koon et al., 2011) NMJs at muscles 12 and 13 of a third 
instar larva expressing mCD8-GFP in type II motorneurons using Tdc2-Gal4, showing 
type I and type II boutons (arrows). Immunostained with anti-HRP and anti-GFP. Anti-
HRP labels all bouton types, whereas anti-GFP labels only type II boutons. Tdc2-Gal4 
labels all tyraminergic and octopaminergic neurons of the nervous system. All Tdc2-
labeled type II motorneurons at the NMJ contains tyramine-beta-hydroxylase (TBH), 
indicating that all type II motorneurons contain octopamine. Scale bar = 9 µm. 
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Figure 1-4 
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Figure 1-4.  
Top panel: Ventral ganglion of a third instar larva expressing mCD8-GFP in type II 
motorneurons using Tdc2-Gal4. Labeled with anti-GFP. Similar to the body wall 
muscles, the ventral ganglion is also divided into 7 segments. Octopaminergic type II 
motorneurons from each segments of the ventral ganglion innervate corresponding 
segments of the larval body wall.  
Bottom panel: Higher magnification of the ventral ganglion of a different animal of the 
same genotype. Scale bar = 50 µm in top panel and 20 µm in bottom panel. 
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Figure 1-5 
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Figure 1-5. A single nerve of a third instar larva expressing mCD8-GFP in type II 
motorneurons using Tdc2-Gal4. Three type II motorneurons axons are observed per 
nerve. Scale bar = 7 µm 
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      Figure 1-6 
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Figure 1-6.  
Top panel: Schematic diagram of type II motorneurons innervating multiple body wall 
muscles. Green: Type II motorneurons originate from 3 cell bodies per segment in the 
ventral ganglion. Bright red muscles: Innervated by type II terminals. Maroon muscles 
(muscle 3 to 7): Not normally innervated by type II terminals.  
Bottom panel: (Adapted from Monastirioti et al., 1995) Probability of type II innervation 
on each of the thirty body wall muscles. Notice the absence of type II on most of the 
internal muscles that are located near internal organs. INT: Internal muscles; EXT: 
External muscles; SUP: Superficial muscles. 
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ABSTRACT 
Adrenergic signaling has important roles in synaptic plasticity and metaplasticity. 
However, the underlying mechanisms remain poorly understood. Here we examined the 
role of octopamine, the invertebrate counterpart of adrenaline and noradrenaline, in 
synaptic and behavioral plasticity in Drosophila. We show that an increase in locomotor 
speed induced by food deprivation was accompanied by an activity- and octopamine-
dependent extension of octopaminergic arbors, and that the formation and maintenance 
of these arbors required electrical activity. We found that octopaminergic arbor growth 
was controlled by a cAMP- and CREB-dependent positive feedback mechanism that 
required Octß2R octopamine autoreceptors. Importantly, this autoregulation was 
necessary for the locomotor response. In addition, octopamine neurons regulated the 
expansion of excitatory glutamatergic neuromuscular arbors, through Octß2Rs on 
glutamatergic motorneurons. These studies provide a mechanism of global regulation of 
excitatory synapses, presumably to maintain synaptic and behavioral plasticity in a 
dynamic range. 
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INTRODUCTION 
Synaptic plasticity is fundamental for an organism’s ability to adapt to a changing 
environment. Adrenergic receptors and their ligands are key regulators of plasticity. 
Noradrenaline is implicated in the retrieval of spatial and contextual memories1, and it 
enhances LTP by promoting the synaptic delivery of AMPA-type glutamate receptors 
(GluR)2. Adrenergic signaling has also been implicated in the regulation of plasticity 
(a.k.a. metaplasticity) to reset a homeostatic circuit in response to acute perturbations, 
thus maintaining the circuit within a dynamic range 3. However, the specific mechanisms 
by which adrenergic signals influence synaptic plasticity are still poorly understood. 
Octopamine, the invertebrate counterpart of adrenergic ligands, activates receptors 
resembling adrenergic receptors4. Octopamine plays a key role in appetitive 
reinforcement in honeybees5 and flies6,7 and modulates behaviors such as aggression8, 
egg-laying9, food-seeking10, and sleep11, as well as synaptic functions12. 
The Drosophila larval neuromuscular junction (NMJ) is a powerful model system to 
investigate synaptic plasticity. While glutamate is the primary excitatory 
neurotransmitter, larval NMJs are also innervated by octopaminergic motorneurons13. 
Larval NMJs display several forms of synaptic plasticity, such as continuous expansion 
during larval development, to offset a massive increase in muscle size, as part of a 
homeostatic mechanism to maintain synaptic efficacy14. This process depends on 
signaling mechanisms such as the BMP15 and Wnt pathways16. Larval NMJs can also 
respond to changes in the environment, such as food availability, by rapid increases in 
synapse strength17,18. In addition, genetic and physiological manipulations that increase 
presynaptic activity promote synaptic expansion19,20. To determine the significance of 
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octopaminergic innervation of body-wall muscles, we examined octopaminergic 
terminals during larval foraging behavior. Type II arbors responded to food deprivation 
by extending new endings. This depended both on activity levels and octopamine. 
Electrical activity at octopaminergic neurons was essential for initial and continued type 
II innervation of muscles. We uncovered a cAMP and CREB-dependent autoregulatory 
positive feedback mechanism that regulated the size of type II endings through the 
activation of Octß2R autoreceptors. Type II innervation also regulated the plasticity of 
glutamatergic type I motorneurons through Octß2Rs expressed in these neurons. Both 
the autocrine and paracrine mechanisms were required for the adaptive response to 
starvation.  
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RESULTS 
Locomotor-increase associates with type II synaptic change 
Larval NMJs respond to acute changes in presynaptic activity by modifications in 
synaptic structure20. However, the physiological conditions under which this mechanism 
is used by the intact organism are unknown. Larval foraging behavior is enhanced by 
food deprivation, which leads to long-lasting enhancement in evoked glutamate release 
from excitatory type I NMJs17. However, no gross changes in the structure of these 
endings were observed17. Most body-wall muscles are co-innervated by at least one 
additional class of motorneuron, the octopaminergic type II motorneurons13 (Fig. 2-1A). 
Octopamine signaling has been implicated in appetitive behaviors and 
locomotion6,10,21,22. Thus, to determine if type II arbors changed structure during 
starvation, a physiological stimulus that increases locomotor activity, these arbors were 
labeled by expressing mCD8-GFP by using a tyrosine decarboxylase-2 promoter fused 
to Gal4 (Tdc2-Gal4; Fig. 2-1A). NMJs from intact early 3rd-instar larvae were imaged live 
through the cuticle, subsequently deprived of food for 2 hrs, and the same NMJs were 
re-imaged. 
Food-deprived wild-type larvae showed a significant increase in locomotor speed 
compared to fed-controls (Fig. 2-1C). Notably, type II endings from starved larvae 
showed dynamic filopodia-like extensions (synaptopods) that extended and retracted 
with a time course of minutes (Fig. 2-1B,D; Movie1). While synaptopods were also 
observed before food deprivation (a.k.a. “natural synaptopods”; Fig. 2-1B), the number 
of synaptopods was significantly increased upon starvation (Fig. 2-1B,D). Thus, 
changes in locomotor activity are accompanied by structural changes at type II endings. 
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We next investigated whether type II endings were necessary for behavior. We 
eliminated octopaminergic neurons by expressing the cell death protein Head Involution 
Defective (Hid; Fig. S2-1), which substantially reduced locomotion speed and the 
starvation response (Fig. 2-1E,F). A similar result was observed in tyrosine-ß-
hydroxylase (tbhnM18) and tdc2 R054 mutants, which are unable to synthesize octopamine 
(Fig. 2-1E,F)9,23.  The defects in tbh mutants were specific, as they were significantly 
rescued by expressing a TBH transgene in octopaminergic neurons (Fig. 2-1E,F). Thus, 
the increase in locomotion elicited by food deprivation results in structural changes in 
octopaminergic endings, and octopamine innervation is necessary for this behavior. 
We then examined whether octopamine was sufficient to increase locomotor activity 
in the absence of starvation. Channelrhodopsin-2 (ChR2) was expressed in 
octopaminergic neurons, and the neurons stimulated by blue light prior to the locomotion 
assay. Stimulated animals had a significant increase in locomotor speed and this effect 
was eliminated in tbh mutants (Fig. 2-1G). Thus, octopamine neurons are necessary 
and sufficient to increase locomotion.  
 To determine if octopaminergic innervation of body-wall muscles alone was 
sufficient for modifications in synaptic physiology, we applied exogenous octopamine to 
body-wall muscles devoid of central input. Bath application of 10µM octopamine elicited 
a 30% increase in the amplitude of excitatory junctional potentials (EJPs) without any 
change in the amplitude of miniature EJPs (mEJPs) (Fig. 2-1H,J).  This was consistent 
with analysis of tbh mutants, in which EJP amplitude was significantly decreased (Fig. 
2-1I,J). Thus, changes in locomotor activity are accompanied by growth of synaptopods 
and likely by an increase in synaptic strength. 
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Synaptopod extension precedes type II synapse formation 
 The physiological significance of synaptopods was determined by examining their 
dynamics (Fig. 2-2A; Movie1). Many synaptopods formed varicosity-like structures at 
their tip, measuring 0.6±0.04 µm in diameter (Fig. 2-2B; Movie2), smaller than mature 
type II boutons (1.57±0.05 µm). Upon new varicosity formation synaptopod motility 
halted (Movie2), the varicosity enlarged, and sometimes a new motile synaptopod 
emerged from that varicosity (secondary synaptopod; Fig. 2-2C; Movie 3). Thus, 
synaptopod formation could be a mechanism for type II arbor extension. This possibility 
was investigated by examining the same type II NMJ from 1st to 3rd-instar larval stage. 
First-instar type II arbors displayed synaptopods (Fig. 2-2D, e.g. red arrow; Fig. S2-2A) 
and synaptopods containing a varicosity at their tip (Fig. 2-2D, e.g. yellow arrowhead in 
inset; Fig. S2-2A). These structures developed into a completely new or extended a 
type II branch (Fig. 2-2D; Fig. S2-2A). To demonstrate that newly formed varicosities 
corresponded to new boutons, larvae expressing both mCherry and GFP-tagged 
Synaptotagmin-1 (Syt-GFP) were imaged as above. Syt-GFP accumulated within the 
newly formed varicosity (Fig. 2-2E). Thus, synaptopod extension is a mechanism to 
expand type II arbors, both during an acute increase in locomotor speed, and during 
larval development.  
We also labeled preparations with antibodies to different synaptic markers. 
FasciclinII (FasII) was present at 100% of synaptopods from the earliest stages (Fig. 2-
2F; Fig. S2-2B), and was maintained throughout subsequent stages of bouton 
maturation (Fig. 2-2L,M). In contrast, Synaptotagmin-1 (Syt1) was observed within 
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synaptopods only 40% of the time (Fig. 2-2G,L,M; Fig. S2-2C), while it was always 
present at the onset of varicosity formation (Fig. 2-2L,M; Fig. S2-2D), suggesting that 
vesicles begin to traffic into synaptopods even before type II varicosity formation. 
 The onset of octopamine synthesis was determined by using antibodies to TBH 
(Fig. S2-3A-F), which demonstrated that TBH was never observed before the onset of 
new varicosity formation (Fig. 2-2H,L,M; Fig. S2-2B-F), suggesting that the 
accumulation of another type of synaptic vesicle, marked by Syt1, preceded the 
accumulation of TBH-containing vesicles. Active zones were identified using anti-
Bruchpilot (Brp; Elks/Cast/Erc homolog)24, which was observed in 27% of enlarged 
varicosities and after the appearance of TBH (Fig. 2-2I,L,M; Fig. S2-2E)20,25,26. Lastly, 
the MAP1B-related protein, Futsch, was only observed after a secondary varicosity was 
formed, but the immunoreactivity was punctate (Fig. 2-2J,L,M; Fig. S2-2F). We were 
unable to determine the onset of postsynaptic GluRs, as the level of immunoreactivity 
was very low (Fig. S2-4A). The above data further support the notion that synaptopod 
extension constitutes a mechanism for the formation of new type II synaptic boutons. 
Indeed, even within intact larvae many of the synaptopods formed after starvation, 
developed varicosities (Fig. 2-2K). These observations also demonstrate that the 
formation of type II boutons follows a precise sequence of synaptic protein addition (Fig. 
2-2L).  
 
Acute activity and octopamine initiates type II outgrowth  
 The structural changes observed at type II boutons in intact larvae raised the 
possibility that octopaminergic neurons were activated during food deprivation or 
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increased locomotion, leading to the expansion of type II arbors. This hypothesis was 
tested by increasing motorneuron activity either with high-K+-induced depolarization, or 
by blue light stimulation of ChR2 expressed in octopaminergic neurons. Preparations 
were subjected to spaced stimulation, in which each of 5 cycles of stimulation with either 
high-K+ or blue light was separated by 15 min rest periods 20. Identified type II endings 
were imaged before and after stimulation. Stimulated samples showed a significant 
increase in synaptopod number at type II endings after stimulation (Fig. 2-3A,C). As in 
intact larvae, natural synaptopods were also observed in unstimulated preparations, 
albeit at a lower frequency (Fig. 2-3A,B). Thus, similar to the starvation response, 
synaptopods at type II endings increased in frequency in response to spaced 
stimulation, and just stimulation of octopamine neurons alone was sufficient to elicit this 
response. This was confirmed by genetically increasing activity at octopaminergic 
neurons by expressing a dominant-negative Shaker K+ channel subunit (ShDN)27 in type 
II motorneurons of an ether a go-go (eag) K+-channel subunit mutant, which resulted in 
an increase in natural synaptopods (Fig. 2-3D). 
Next, we sought to determine if octopamine signaling could underlie the effects of 
activity. Eliminating octopamine in tbh null mutants resulted in a significant decrease in 
natural synaptopods (Fig. 2-3D). In contrast, bath application of octopamine for 15 min 
to wild-type preparations resulted in a dose-dependent increase in the number of 
synaptopods, while tyramine application was without effect (Fig. 2-3B,E,F). Induction of 
synaptopods by octopamine required normal (1.5 mM) Ca++ levels, as decreasing Ca++ 
to 0.1 mM, prevented this effect (Fig. 2-3E; sub-Ca++). 
39 
 
  
The relationship between activity and octopamine was determined by stimulating 
the terminals with subthreshold parameters for induction of synaptopods by activity and 
octopamine. If the effect of activity was to increase octopamine release, then presenting 
both subthreshold stimuli together should elicit significant synaptopod formation. The 
subthreshold stimuli consisted of 3 cycles of spaced depolarization and application of 10 
µM octopamine in 0.1 mM Ca++, both of which were insufficient to induce synaptopods 
when presented alone (Fig. 2-3G). When applied together, however, they were sufficient 
to increase synaptopods to a level similar to 5 cycles of stimulation alone (Fig. 2-3G). 
Thus, exogenous octopamine can overcome the effect of insufficient activity for the 
induction of synaptopods, and vice versa, consistent with the notion that synaptopod 
formation is the result of activity-dependent octopamine release.  
Surprisingly, octopamine failed to induce synaptopods in tbh mutants (Fig. 2-3E). 
Given that tbh mutants have an accumulation of tyramine9 that might be 
developmentally deleterious, we also tested tdc2 mutants, which lack tyramine 
accumulation. In tdc2 mutants the response to octopamine was normal (Fig. 2-3E), 
suggesting that in tbh mutants the accumulation of tyramine renders the NMJs 
insensitive to exogenous octopamine.   
We also examined synaptic growth by counting the number of type II boutons at the 
last stage of larval development. Increasing activity through expression of ShDN in 
octopaminergic neurons of eag mutants, led to a significant increase in the number of 
type II boutons and terminal branches (Fig. 2-3H; Fig. S2-5A). In contrast, in tbh 
mutants the number of type II boutons and branches was decreased (Fig. 2-3H; Fig. 
S2-4B). These phenotypes were specifically rescued by expressing a tbh transgene at 
40 
 
  
octopaminergic neurons (Fig. 2-3H; Fig S2-4B). The defect in tbh mutants was not due 
to the accumulation of tyramine in these mutants, since a null mutant in tdc2, which 
lacks tyramine in addition to octopamine, also showed a decrease in type II bouton 
number (Fig. 2-3H). 
 
Type II synaptogenesis and maintenance requires activity 
We also used transgenic approaches to block activity at octopaminergic neurons, 
including ShiDNts, which blocks vesicle recycling at restrictive temperatures28, EKO, a 
hyperpolarizing Shaker potassium channel29, and Kir2.1, which encodes an inward-
rectifying K+ channel that prevents membrane depolarization30. The efficiency of the 
blockade was tested by examining the ability of adult females to lay eggs, as 
octopamine function is required for egg-laying9. Only expression of Kir2.1 resulted in 
complete egg-laying block (data not shown). Strikingly, it also resulted in the complete 
elimination of type II innervation (Fig. 2-4A,B). This was not due to a pathfinding or cell 
death defect since type II motorneuron axons, labeled with mCD8-GFP, were always 
observed in the segmental nerves (Fig. 2-4C,D). In 69% of the nerves examined, these 
axons stalled within the segmental nerve. However, in 31% of the cases axons traveled 
the entire distance from the CNS and stalled close to the NMJ without innervating the 
muscles (Fig. 2-4D). Thus, in the absence of activity, type II endings are incapable of 
innervating body-wall muscles.  
Although ShiDNts did not completely eliminate octopaminergic function, expressing 
this transgene and rearing the animals at the restrictive temperature of 29oC 
developmentally were sufficient to elicit marked abnormalities in the innervation of 
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muscles by type II endings. These included drastically reduced type II arbors (Fig. S5B), 
lack of innervation of muscles by type II arbors (Fig. S2-5D), thinning of type II neurites 
(Fig. S2-5F,H), and lack of TBH in some type II boutons (Fig. S2-5H).  
 To determine if there was a critical period in which activity was required for type II 
innervation, and whether the lack of innervation was the result of activity-dependent 
synaptogenesis or degeneration, first, we determined when type II innervation was 
established during the larval period, and the consequences of blocking activity at these 
stages. Type II varicosities were first observed during the 1st-instar stage (Fig.2-4E,G). 
Blocking activity eliminated type II boutons at any larval stage (Fig.2-4F,H), suggesting 
that the absence of activity in type II motorneurons prevents synaptogenesis.  
As a second approach, we ubiquitously expressed a temperature-sensitive Gal80, 
which at 18˚C blocks Gal4-mediated expression31, and Kir2.1 was simultaneously 
expressed at octopaminergic neurons. Larvae were raised at 18˚C, and then switched to 
29˚C at different stages to permit expression of Kir2.1. Suppressing the activity of 
octopaminergic neurons 24 hrs before the 3rd-instar stage, did not elicit any abnormality 
in type II bouton morphology (Fig. 2-4I). In contrast, blocking activity starting from late 
2nd-instar resulted in breaks in type II arbors (Fig. 2-4J). The severity of this phenotype 
was most pronounced when activity was blocked from late 1st-instar larval stage (Fig. 2-
4K,L,M). Thus, activity in type II endings is required for synaptogenesis, whereas 
prolonged periods of inactivity after innervation leads to the degeneration of type II 
endings. 
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Octopamine-induced type II outgrowth requires cAMP and dCREB 
 The finding that octopamine induced the growth of type II arbors, suggested an 
autoregulatory mechanism controlling the formation of type II endings. Octopamine 
could be acting on autoreceptors at type II endings, or alternatively, octopamine might 
activate a retrograde signal that promotes the growth of type II boutons. Octopamine 
receptors are G-protein-coupled receptors, which can increase Ca++ and/or cAMP4,32. 
Previous studies had suggested that increasing cAMP levels by a mutation in the 
phosphodiesterase Dunce (Dnc) induced an enhancement of synaptic growth in all 
boutons33. Therefore we examined whether manipulating the levels of cAMP at type II 
motorneurons could influence synaptopod formation in response to octopamine. 
Mutations in dnc elicited significant enhancement in the number of naturally occurring 
synaptopods at type II endings (Fig. 2-5A,B,D). This phenotype was rescued by 
expressing Dnc exclusively in the octopaminergic neurons of dnc mutants or by a 
genomic duplication (Dp) of dnc (Fig. 2-5D). Thus, octopamine motorneurons contain a 
cAMP pathway that can promote synaptopod formation. 
These observations were confirmed by using a mutation in rutabaga (rut) encoding 
an adenylate cyclase, and thus decreasing cAMP levels. rut2080 mutants had significantly 
fewer natural synaptopods and this phenotype was rescued by expressing Rut at 
octopaminergic neurons (Fig. 2-5D). 
To determine if cAMP was acutely sufficient for synaptopod induction, we elevated 
cAMP levels using a photoactivatable adenylate cyclase (PACα)34. We expressed PACα 
at octopaminergic neurons and light-stimulated the preparation with blue light using a 
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spaced paradigm. A highly significant increase in the number of synaptopods was 
observed (Fig. 2-5C,E; Movie4), demonstrating that acute changes in cAMP levels are 
sufficient for the induction of synaptopods.  
To determine if cAMP was downstream of activity and octopamine in the induction 
of synaptopods, we applied octopamine in dnc and rut mutants. As described above, 
dncM14 mutants have an increased number of naturally occurring synaptopods, while 
rut2080 mutants show a decrease in this number. In dnc mutants we expected that the 
increase in synaptopods by octopamine would be occluded, as natural synaptopods are 
already saturated in this mutant. In the case of rut mutants, we expected that the 
decrease in adenylate cyclase activity would render NMJs unresponsive to octopamine. 
Consistent with these predictions, octopamine failed to increase the number of 
synaptopods in the two mutants (Fig. 2-5F). In contrast, increasing cAMP by activating 
PACα in a tbh mutant background still induced synaptopods (Fig. 2-5E). Thus the cAMP 
pathway is likely downstream of octopamine during synaptopod induction.  
The cAMP pathway during long-term plasticity has been associated with the 
activation of CREB leading to the transcription of genes required for new synapse 
formation35. We sought to determine if the growth of type II endings in response to 
octopamine release required dCREB function. We expressed a dCREB dominant-
negative transgene (CREBdn/dCREB2-b) previously shown to block CREB function36, in 
octopamine neurons, which suppressed the increase in octopamine-induced synaptopod 
formation (Fig. 2-5G). Similarly, the translational inhibitor cycloheximide and the 
transcriptional inhibitor actinomycin-D completely suppressed octopamine-dependent 
synaptopod formation (Fig. 2-5G). Thus, the autoregulatory mechanism that initiates the 
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formation of new type II boutons activates a cAMP cascade that depends on CREB-
mediated transcription.  
 As perturbations in the cAMP pathway altered synaptopod formation, and 
mutations preventing an increase in synaptopod formation in response to octopamine 
also showed behavioral defects, we predicted that similar behavioral defects would be 
observed in dnc and rut mutants. Interestingly, although dncM14 mutants showed a 
decreased locomotor speed and rut mutants had normal locomotor speed (Fig. 2-5H), 
the response to starvation was blocked in both mutants, similar to tbh mutants (Fig. 2-
5I). The behavioral defect in rut mutants was completely rescued by expressing a Rut 
transgene in octopaminergic neurons (Fig. 2-5I). Thus, normal cAMP levels in 
octopaminergic neurons are required for the response to starvation, and at least in the 
case of Rut, the starvation response can be separated from a defect in basal 
locomotion.  
 
Octß2R autoreceptors mediate the autoregulatory mechanism 
 Presynaptic octopamine autoreceptors are plausible candidates for mediating 
autoregulation of synaptic structure. Four octopamine receptors have been identified in 
the Drosophila genome, OAMB, Octß1R (also called OA2), Octß2R, and Octß3R. 
OAMB receptors have homology to mammalian α-adrenergic receptors and can 
increase Ca2+ or cAMP levels4,32. Octß1R, Octß2R, and Octß3R receptors have been 
less studied, but share similarities with mammalian ß-adrenergic receptors and are 
thought to increase cAMP. We interfered with the function of OAMB and Octß2R.In the 
oamb584 genetic null allele37, the number of natural synaptopods, the induction of 
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synaptopods by octopamine, and the number of type II boutons were normal (Fig. 2-6A-
C).  
In the case of Octß2R, we used a hypomorphic allele11, as well as UAS-Octß2R-
RNAi. We also verified that Octß2R was expressed in the nervous system and body-wall 
muscles (either pre- or postsynaptically) and the effectiveness of the RNAi transgene by 
RT-PCR (Fig. S2-6A,B). In octß2R mutants the number of natural synaptopods was 
significantly decreased (Fig. 2-6A) placing it as the likely mediator of the cAMP-
dependent autoregulatory mechanism that controls the growth of type II endings. 
Accordingly, octß2R mutants did not show increased synaptopods in response to 
octopamine (Fig. 2-6C). This effect was cell autonomous, as expressing Octß2R-RNAi 
in octopaminergic neurons alone was sufficient to decrease the number of natural 
synaptopods (Fig. 2-6A) and to suppress the increase in synaptopods upon octopamine 
application (Fig. 2-6C). In addition, either the octß2R mutant or expression of Octß2R-
RNAi in octopamine neurons resulted in a significant decrease in the number of type II 
boutons (Fig. 2-6B). Expressing Octß2R-RNAi in both type I and type II motorneurons 
by using C380-Gal4, also resulted in a significant reduction in the number of type II 
boutons (Fig. 2-6B). In contrast, expressing Octß2R-RNAi in muscles using C57-Gal4 
was without effect. Taken together, these observations identify Octß2R receptors as the 
likely autoreceptor that regulates the growth of type II boutons. 
 Interestingly, the octß2R mutant had a reduction in evoked EJP amplitude similar 
to tbh mutants (EJP amplitude = 18.3±1 mV in wild type, vs 12.1±1 mV in octß2R 
mutants; N=7; p<0.001), suggesting that either removing octopamine, or the receptor 
decreases synaptic strength. As expected, bath application of octopamine to octß2R 
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mutants did not change EJP amplitude as observed in wild type (ratio EJP amplitude is 
0.95 upon 10µM octopamine application vs 1.33 in wild type; N=5; p<0.005). Thus, 
Octß2R receptors are likely responsible for the octopamine induced changes in synaptic 
strength. 
 We predicted that removing the receptor would also eliminate the starvation 
response. octß2R mutants failed to respond to starvation by increasing locomotor speed 
(Fig. 2-6D). This defect was also observed when Octß2R was downregulated either in 
octopamine neurons or both in type I and type II motorneurons, but not in muscles (Fig. 
2-6D).  
 
Type II endings regulate type I synaptic bouton outgrowth 
 Excitatory transmission at the larval NMJ is mediated by the release of glutamate 
from type I NMJs. Similar to type II arbors, type I arbors continuously expand throughout 
larval development, in strong correlation to muscle size38. We considered the possibility 
that type II innervation might regulate this form of plasticity at type I boutons. To test this 
possibility, we first eliminated type II boutons by expressing Hid in octopaminergic 
neurons. Notably, the absence of type II innervation led to a substantial reduction in the 
number of type I boutons (Fig. 2-7A; Fig. S2-6C). Similar results were obtained by 
expressing Kir2.1 or in tbh mutants (Fig. 2-7A). The reduction in the number of type I 
boutons in tbh mutants was restored by expressing a tbh transgene in octopamine 
neurons (Fig. 2-7A). These results suggest that type II innervation regulates the 
plasticity of type I endings and therefore it is involved in a form of metaplasticity.   
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To further characterize the influence of type II endings on type I arbors, we 
examined octß2R mutants, and observed a reduction in the number of type I boutons 
(Fig. 2-7B). A potential mechanism by which type II arbors might regulate the growth of 
type I endings is through the presence of octopamine receptors at type I boutons. 
Therefore, we used the C380-Gal4-driver to downregulate Octß2R in both type I and 
type II motorneurons, and BG439-Gal4, which drives Gal4 expression in type I 
motorneurons but not in type II motorneurons (Fig. 2-S7). Both manipulations resulted in 
a highly significant decrease in the number of type I boutons (Fig. 2-7B). In contrast, 
downregulating Octß2R at octopamine neurons alone did not result in a significant 
decrease in the number of type I boutons. These results suggest that Octß2R is required 
in type I motorneurons for normal expansion.  
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DISCUSSION 
Adrenergic signaling is involved in the regulation of synaptic plasticity39,40. However, 
the precise mechanisms for this regulation are poorly understood. We show that 
octopamine regulates behavioral and synaptic plasticity through an autoregulatory 
mechanism that promotes the growth of type II innervation and in turn the expansion of 
excitatory glutamatergic arbors. Importantly, this process appears associated with 
physiological stimuli that lead to increased locomotion. We propose that food deprivation 
elicits the release of octopamine by type II terminals. Octopamine binds to Octß2R 
receptors resulting in the increase of cAMP, which activates CREB-dependent 
regulation of transcription, leading to new type II synaptic growth (Fig. S2-8A). This 
autoregulatory mechanism might serve to control the amount of octopamine released by 
type II arbors. In turn, octopamine release stimulates the growth of type I arbors through 
Octß2R at type I motorneurons. This mechanism would therefore regulate, in a global 
fashion, excitatory transmission at the NMJ (Fig. S2-8A).  
Increasing larval locomotion, type II motorneuron activity, or exogenous octopamine 
levels resulted in the extension of synaptopods. Taken together with the demonstration 
that synaptopod extension constitutes a mechanism for the formation of type II boutons, 
these results suggest that the above events serve to control the growth of 
octopaminergic endings in an acute manner. Analysis of mutations in octopamine 
receptors and components of the cAMP cascade demonstrated the presence of an 
autoregulatory mechanism to control this growth. First, type II motorneuron expression 
of Octß2R was required for type II synaptic growth. Second, altering cAMP levels by 
mutations in dnc or rut modified this response in a manner consistent with positive 
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regulation by cAMP. This regulation was cell autonomous in octopaminergic 
motorneurons, as the defects in synaptopod formation and type II synaptic growth were 
also elicited or rescued by transgene expression in octopaminergic motorneurons alone, 
in a chronic or acute manner. The presence of auto-octopamine receptors had been 
suggested in locusts41, although the identity of the proposed autoreceptor was not 
known. However, it was proposed that the locust octopamine autoreceptors served to 
inhibit octopamine release. In contrast, our experiments are consistent with a positive 
feedback mechanism that enhances synaptic growth. Autoregulatory mechanisms that 
control the amount of neuromodulator release have been previously demonstrated for 
neuromodulators such as dopamine42.  
Intriguingly, as in other forms of synaptic plasticity, including late LTP and long-term 
memory35, the autoregulatory mechanism required the function of CREB and new 
protein synthesis. This finding underscores the universality of mechanisms by which the 
nervous system modifies the efficacy of connections in a long-lasting manner. 
Octopamine receptor activation leading to CREB signaling has also been demonstrated 
in C. elegans10.  
Our studies revealed that this pathway regulated the structure of octopaminergic 
arbors in an autoregulatory fashion, and that this influenced the growth of type I 
excitatory arbors. The presence of a positive feedback that controls the growth of 
modulatory inputs in an acute manner is highly significant, as it provides a novel 
mechanism by which animal experience can modify circuitry and thus adapt to a 
changing environment.  
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 Activity was absolutely required for innervation of body-wall muscles by type II 
arbors, as reduced activity perturbed type II synaptogenesis. This is in contrast to the 
widely held view that while activity is important for the refinement of connections, it is not 
required for initial synaptogenesis43. Part of this view arises from the examination of 
arbors mediating classical neurotransmission43. In contrast, the activity dependence of 
modulatory terminal growth has been less studied. Our studies provide compelling 
evidence that octopamine has an influence on both octopaminergic type II and type I 
bouton outgrowth. Studies of type I bouton outgrowth have identified local factors that 
influence the development of pre- and/or postsynaptic compartments, including Wnts 
and BMPs15,16. We suggest that octopamine release by type II arbors might put forth a 
more global regulation of outgrowth. 
 At the Drosophila larval NMJ, glutamatergic type Ib motorneurons innervate each 
muscle in an approximately 1:1 manner44 (Fig. S2-8B; type Ib). In addition, 2 
glutamatergic type Is motorneurons innervate the entire ventral or dorsal muscle field 
within each hemisegment44,45 (Fig. S2-8B; type Is). In contrast, the 3 octopaminergic 
neurons per segment innervate the majority of the body-wall muscles in a bilateral 
fashion (13 and this report; Fig. S2-8B; type II). The layout of this innervation suggests 
that type II synapses might establish global regulation of the plasticity of type I arbors. 
This might serve as a mechanism to set excitability levels in the entire body-wall, and 
thus maintain synaptic function within a dynamic range. Similarly, studies in mammalian 
systems have demonstrated that adrenergic signaling can affect glutamatergic synapse 
plasticity, either through changes in ionotropic GluR localization2, or through regulation 
of metabotropic GluR, affecting the ability of a synapse to become potentiated 
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depending on its history3. Octopamine might regulate the ability of type I NMJs to trigger 
muscle contraction by long-term regulation of type I synaptic growth.  
Two previous studies at the Drosophila larval NMJ have demonstrated an 
enhancement of synaptic transmission in response to octopamine46,47. However, another 
study suggests that octopamine may inhibit glutamatergic transmission in 1st-instar 
larvae48. Our studies suggest that blocking activity or interfering with octopamine 
signaling in type II neurons, leads to a decrease in type I synaptic outgrowth, consistent 
with octopamine release as a positive regulator of type I transmission. We suggest that 
in the short-term, octopamine enhances synaptic strength, as observed in our 
electrophysiology experiments, leading to the observed increase in crawling behavior 
after starvation. This would be consistent with studies showing that food deprivation 
induced increases in locomotor speed lead to an enhancement of synaptic efficacy17. 
 Octopamine is a potent modulator of invertebrate behaviors and has been shown 
to be secreted during starvation in invertebrates10,22. Nevertheless, its function at the 
synaptic level is poorly understood. Our study, for the first time, demonstrates that 
octopamine can influence synapses at the structural level through the activation of 
Octβ2R autoreceptors in octopamine neurons and through the presence of these 
receptors in type I motorneurons.  
An important question is whether octopamine is simply involved in locomotion, and 
the lack of starvation response in mutants unable to synthesize octopamine is an 
indirect effect from defective locomotion. It is not possible to answer this question in tbh 
mutants, since basal locomotion was reduced in these mutants. However, our 
experiments revealed conditions in which changes in basal activity could be genetically 
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separated from changes in the starvation response. One such case is rut mutants, which 
have normal locomotion, but lack starvation response. This effect appeared to be due to 
the function of Rut in octopamine neurons, as the defective starvation response was 
completely rescued by expressing a Rut transgene in octopamine neurons. A second, 
although somewhat less clear observation is regarding octß2R mutants. While baseline 
locomotion was much less altered in these mutants, compared to tbh mutants, these 
animals were still unable to mount a starvation response (Fig. 2-6D,E). Thus, it is quite 
likely that octopamine neurons are not only involved in locomotion, but also in the 
response to starvation.  
Octopamine is also known to be required for appetitive memory in adult fruit flies7. 
Notably, the appetitive memory paradigm requires starvation prior to the assay, and tbh 
mutants are unable to learn in this paradigm. Octopamine has been proposed to 
mediate the reinforcing effects of sugar in appetitive memory formation5,7. Our studies 
raise the possibility that this mechanism may involve structural changes at synaptic 
sites. 
Although our studies focused on structural changes at type II NMJs, many of our 
manipulations affected all octopamine neurons, as the Tdc2-Gal4 drives Gal4 in all 
octopaminergic neurons. Thus, our studies cannot rule out an influence from other 
octopaminergic neurons, besides motorneurons, in the changes observed and in the 
behavior. However, the finding that the manipulations resulted in specific changes in 
type II NMJ terminals, and that octopamine modulates synaptic strength at the NMJ 
argues that at least some of the effects observed are likely to be due to the peripheral 
octopamine innervation. 
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In summary, our studies reveal important mechanisms by which activity regulates 
the ability of motorneurons to scale the release of regulatory signals, which is important 
for the adaptation of the organism to the environment. In addition, they provide a 
mechanism by which excitatory synapses are regulated in a global manner, presumably 
to maintain synaptic plasticity in a dynamic range. 
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MATERIALS AND METHODS 
Fly strains. Flies were reared in standard Drosophila medium at 25 °C except where 
indicated. Animals used in RNAi experiments were reared at 29 °C to increase 
knockdown efficiency. The following stocks were used: the wild-type strain Canton-S 
(CS), Tdc2-Gal4 (Bloomington Stock Center), UAS-Hid49, tbhnM18, tdc2RO54 (ref. 23), 
UAS-Kir2.1 (ref. 30), tubP-Gal80ts (Bloomington), UAS-ShDN27, eag1 (Bloomington), 
UAS-mCD8-GFP (Bloomington), y dncM14 cv f (Bloomington) y w dncML f36a 
(Bloomington), UAS-Dnc (remobilized to the second chromosome)50, rut2080 
(Bloomington), UAS-Rut (Bloomington), UAS-dCREB2-b (Bloomington), oamb584 (ref. 
37), Pbac{WH}Octβ2R[f05679] (Bloomington), Dp(1;2)51b (duplication of dnc; 
Bloomington), UAS-Syt1-GFP (Bloomington), C380-Gal4 (Budnik et al., 1996), BG439 
(V. Budnik, unpublished), UAS-Dicer-2 (Bloomington), UAS-Octβ2R-RNAi (8486 and 
104524; Vienna Drosophila RNAi Center) and UAS-PACα (see below). 
Generation of PACα flies. Euglena gracilis PACα cDNA was provided by M. Watanabe. 
A 3,104-bp EagI fragment encompassing the full-length PACα cDNA with 5′ leader 
sequence was ligated into the EagI site of the Drosophila transformation vector pUAST. 
The insert was verified to be in the appropriate orientation by PCR and end sequencing, 
and transformed into flies by germline transformation. 
Generation of TBH antibodies. TBH antibodies were raised against amino acids 277–
670 of TBH, which is the following peptide sequence: 
QETTYWCHVQRLEGNLRRRHHIVQFEPLIRTPGIVHHMEVFHCEAGEHEEIPLYNGDC
EQLPPRAKICSKVMVLWAMGAGTFTYPPEAGLPIGGPGFNPYVRLEVHFNNPEKQSGL
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VDNSGFRIKMSKTLRQYDAAVMELGLEYTDKMAIPPGQTAFPLSGYCVADCTRAALPA
TGIIIFGSQLHTHLRGVRVLTRHFRGEQELREVNRDDYYSNHFQEMRTLHYKPRVLPGD
ALVTTCYYNTKDDKTAALGGFSISDEMCVNYIHYYPATKLEVCKSSVSEETLENYFIYMK
RTEHQHGVHLNGARSSNYRSIEWTQPRIDQLYTMYMQEPLSMQCNRSDGTRFEGRS
SWEGVAATPVQIRIPIHRKLCPNYNPLWLKPLEKGDCDLLGECIY. The specificity of the 
antibody was demonstrated by the lack of immunoreactivity in null tbhnM18 mutants 
(Supplemental Fig. 2-S1C,F). 
Immunocytochemistry. Larval body-wall muscles were dissected and fixed for 15 min in 
4% paraformaldehyde. For TBH immunocytochemistry samples were fixed in Bouin's 
fixative. Antibodies and their concentrations were: anti-TBH 1:400, anti-mCD8a 1:100 
(Invitrogen), anti-HRP-Texas Red 1:200 (Jackson ImmunoResearch), anti-FasII 1:2 
(Developmental Studies Hybridoma Bank, DSHB), anti-Syt1 1:100 (gift from T. Littleton), 
anti-Bruchpilot 1:100 (nc82; DSHB), anti-Futsch 1:50 (22C10, DSHB), anti-GluRIIA 1:10 
(8B4D2; DSHB). Secondary antibodies conjugated to FITC, Texas Red (Jackson) or 
Alexa 647 (Invitrogen) were used at a concentration of 1:200. Imaging of fixed 
preparations was as described20. 
Animal rearing conditions for synaptopod analysis.All animals used in synaptopod 
analysis carried a copy of Tdc2-Gal4 and a copy of UAS-CD8:GFP. Egg collection was 
done in standard 25-mm diameter cornmeal/agar/molasses food vials at 25 °C with 
~60% humidity, and larvae were kept at low density. Wandering late third-instar larvae 
were used for experiments. 
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Stimulation procedures and live imaging of dissected preparations. Synaptopods were 
imaged from live preparations as described20. Both the spaced high K+ depolarization 
procedure and the ChR2 stimulation procedure were as described20. Briefly, the high K+ 
procedure consisted of 5 incubation cycles with 90 mM K+-containing saline, each 
lasting 2 min and separated by 15-min resting intervals. For the ChR2 stimulation 
procedure, animals were placed inside a drop of HL3 saline (~300 µl) containing 1.5 mM 
Ca2+. The procedure consisted of five cycles of blue light stimulation from four 491-nm 1-
W LEDs placed 1.2 meters away from the animals. Each cycle consisted of a repeating 
5-min procedure of 2 s on and 3 s off, separated by 15-min resting intervals. Saline was 
exchanged once during each resting interval. Animals were imaged 15 min after 
stimulation or subjected to the crawling assay. For octopamine stimulation, larvae were 
dissected in HL3 saline containing 0.1 mM Ca2+ and preparations gently glued onto a 
custom-made glass imaging chamber using surgical glue. Then, identified NMJs were 
imaged on an Improvision spinning disc confocal microscope (PerkinElmer) with a 
C9100-13 Hamamatsu cooled EM-CCD camera and using a 40× 1.2 NA objective, with 
a 2.4× optical zoom. After imaging for less than 30 min, animals were partially unglued 
to allow muscles to contract freely, and 10 µM octopamine in HL3 containing 1.5 mM 
Ca2+ was then applied for 15 min followed by 5 × 15-min washes with 0.1 mM Ca2+ HL3 
saline before imaging again. In some experiments actinomycin D (Sigma) 5 µM in HL3, 
and cycloheximide (Sigma) 100 µM in HL3 were applied throughout octopamine 
incubation and washes. The final concentration of DMSO in these solutions was 
approximately 0.03%. For PACα experiments, NMJs were imaged as above, then 
stimulated with a broad spectrum blue light dental gun placed ~2 cm away. Stimulation 
consisted of 5 × 5-s light exposures, each separated by 2 min rest. 
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Live imaging of intact (undissected) larvae.For live-imaging through the cuticle of intact 
larvae, animals were anesthetized using Sevoflurane (Baxter) and identified NMJs 
(muscle 9, A4) were imaged for not longer than 30 min. Larvae were allowed to recover 
for 1.5 h on food plates and then used for food deprivation experiments (see below) 
before imaging. Larvae that did not recover in 1.5 h after the first imaging session or 
after starvation were discarded. For non-starved controls, larvae were placed in food 
between imaging sessions. 
Crawling assay. Synchronized larvae were grown at 25 °C in 28.5-mm diameter 
standard food vials at low density until mid third-instar larval stage. After washing with 
water, individual larvae were loaded onto a 24 × 24-cm 3% agar plates and allowed a 
pre-run of 25 s on the agar before recordings were made. Larval tracks were then 
recorded manually for 1 min on transparency paper over the plate lid, and the distances 
crawled were measured using ImageJ. All behavioral experiments were carried out in a 
25 °C, 60% humidity behavioral room. n represents one animal. Percentage increase in 
locomotor speed of individual animals was calculated by: (locomotor speed of individual 
animals after starvation minus mean locomotor speed before starvation) × 100 divided 
by the mean locomotor speed before starvation. Mean percentage and s.e.m. were 
calculated. For RNAi experiments, food vials rearing animals at 29oC were incubated at 
25oC for 1 hour prior to crawling assay.  
Starvation assay. Larvae were maintained in food or food-free moisturized 35-mm Petri 
dishes for 2 h and then either assayed for synaptopod formation or subjected to the 
crawling assay. For RNAi experiments, food vials rearing animals at 29oC were 
incubated at 25oC for 1 hour prior to starvation assay. 
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Quantification of boutons and synaptopod number. The number of type I boutons was 
obtained at muscles 6 and 7 of abdominal segment A3, and the number of type II 
boutons was measured at muscle 12 in A3. For muscle area measurements the muscle 
length and width were measured using an ocular scale bar. Measurements of 
synaptopod number were from muscle 12 (A4) in dissected preparations and those from 
intact larvae were from muscle 9 (A4). Numbers of synaptopods in the histograms 
represent the total number of synaptopods per 100 µm of each arbor. Synaptopods were 
defined as such if they measured 0.5 µm or more. n represents number of NMJs. At 
most two NMJs (segment A3) were quantified in each animal. 
Statistical analysis. For comparisons between more than two sample groups an analysis 
of variance (ANOVA) with Tukey post-hoc test was performed. For pair-wise 
comparisons a Student t-test was used. Numbers in histograms represent mean ± s.e.m. 
Unless otherwise noted, sample number (n) represents one synaptic arbor for 
anatomical measurements, or one animal for behavioral analyses. Statistical analysis for 
animals reared at 25oC and animals reared at 29oC are calculated separate.  
Genotype abbreviations. Type II driver control, Tdc2/+; Type I+II driver control, C380-
Gal4/+; muscle driver control, C57-Gal4/+; [transgene]-type II, Tdc2-Gal4>[transgene]; 
[transgene]-type I+II, C380-Gal4>[transgene]; [transgene]-muscle, C57-
Gal4>[transgene] unless otherwise indicated ; Dcr, UAS-Dicer-2. 
Electrophysiology.Membrane potential recordings were performed on dissected third-
instar larvae as described20. Briefly, larvae were dissected in a custom magnetic 
chamber in 0.3 mM Ca2+ HL3 saline, and the A3 segmental nerves carefully cut close to 
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the ventral ganglion. The chamber was then moved to the recording setup where it was 
perfused with 0.5 mM Ca2+ HL3. Muscle 6 in segment A3 was impaled with a 15–20-MΩ 
electrode, and voltage recordings were collected with an Axoclamp2A amplifier 
(Molecular Devices), using Heka Pulse software (Heka). Only samples with resting 
membrane potentials between −60 and −63 mV were considered. For EJP recordings 
the segmental nerve was stimulated with a suction electrode at 0.3 Hz, with a stimulus 
of 0.3 ms and sufficient voltage to evoke responses from both type I boutons. Four 
minutes of both mEJP and EJP data were recorded for each sample. Data was analyzed 
using Minianalysis software (Synaptosoft), and statistical analysis was done with Origin 
software (OriginLab). Bath application of octopamine was performed by changing the 
perfusion solution from 0.5 mM Ca2+ HL3 to 0.5 mM Ca2+ HL3 containing 10 µM 
octopamine. Samples were allowed to equilibrate for 2 min in the new saline, and then 
evoked and spontaneous events were recorded again. Statistical analysis was done as 
above. 
RT-PCR. Total mRNA was extracted from dissected larval body wall muscles or larval 
brains using a combination of Trizol (Invitrogen) and the RNeasy kit (Qiagen). Synthesis 
of cDNA for +RT reactions was performed using the Superscript III kit (Invitrogen), 
where −RT reactions lacked reverse transcriptase. The +RT and −RT reactions were 
then diluted and used for PCR using the forward primer 
CATGCTGATGCACCGACCATC and the reverse primer 
CACTCCTCGCAGGTCATGGAG. These primers were specifically designed to 
recognize all known splice variants of octβ2R, and across two exon-intron junctions to 
avoid false signals from any contaminating genomic DNA. For semiquantitative RT-PCR, 
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we determined the linear range of Octβ2R amplification for the amount of starting cDNA 
(50 ng) and number of PCR cycles for wild type, and then amplified cDNA made from 
RNA isolated from wild type and C380>UAS-Octβ2R-RNAi. 
Quantification of branch-points.Type II arbors were examined in an epifluorescence 
microscope and each branch bifurcation was counted as a single branch point. For 
these quantifications n is the number of total type II arbors (segment A3) quantified for 
each genotype. 
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Figure 2-1 
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Figure 2-1. Food-deprivation increase in larval locomotion is correlated with synaptopod 
formation at type II arbors. (A) NMJs at muscles 12 and 13 of a 3rd-instar larva 
expressing mCD8-GFP in type II motorneurons, showing type I and type II endings 
(arrows), labeled with anti-HRP and anti-GFP. (B) Live imaging of type II endings 
through the cuticle of intact larvae before and after 2-hr starvation. Arrows point to 
synaptopods. (C) Locomotor speed of wild-type (Canton-S) larvae before and after 2-hr 
starvation (N=31,26). (D) Number of synaptopods (pods) in fed and 2-hr starved intact 
Tdc2>mCD8-GFP larvae (N=10,10). (E) Locomotor speed in the indicated genotypes 
(N=31,23,29,15,34,18,25). (F) Percentage increase in locomotor speed in response to 
starvation in the indicated genotypes (N=26,25,15,14,38,14,25). (G) Percentage 
increase in locomotor speed in response to light stimulation in the indicated genotypes 
(N=20,20,16). (H) Ratio of EJP and mEJP amplitude upon bath application of 10 µM 
octopamine (N is 10 animals) (I) EJP and mEJP amplitude in tbh mutants (N is 6, 5, and 
5 animals respectively) (J) Representative EJP traces in the indicated conditions. 
Calibration bar is 8.5µm for A, 7.5µm for B. Error bars represent SEM. 
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Figure 2-2 
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Figure 2-2. Stepwise development of synaptopods. (A, B, C) Time lapse imaging of 
synaptopods in Tdc2>mCD8-GFP larvae showing (A) the extension of synaptopods 
(arrows), (B) the formation of varicosities at the tip of synaptopods (arrows), (C) the 
formation of a secondary synaptopod (arrowhead) from a newly formed varicosity 
(arrow). Images of the same NMJs were taken 45 sec apart. (D) Developmental time-
lapse imaging of the same NMJ through the cuticle of 1st, 2nd and 3rd-instar. Red arrow: 
a synaptopod developed into an entire branch. Orange arrow: a synaptopod was 
eliminated at 3rd-instar. Blue arrow: a synaptopod developed into a varicosity. Yellow 
and purple arrow: a varicosity developed into a new branch. (E) Time lapse imaging as 
in (D) in animals expressing mCherry and Syt-GFP in type II endings in 2nd and 3rd-
instar. Arrow points to a synaptopod that acquired Syt1-containing varicosity. (F-J) 
Sequence of protein addition to an extending type II branch in Tdc2>mCD8-GFP 
preparations triple labeled with anti-GFP, anti-TBH and antibodies to (F) FasII, (G) Syt1, 
(H) TBH, (I) Brp, and (J) Futsch. Arrows point to sites of protein localization at 
synaptopods or newly formed varicosities. (L) Diagrammatic representation of 
developing type II endings showing the sequence of synaptic protein addition. (M) 
Percentage of synaptopods showing the presence of the indicated proteins at the stages 
of synaptopod, varicosity at the tip of a synaptopod (ball on pod), and secondary 
synaptopod (pod on ball). N (number of pod structures) is FasII=30, Syt1=30, TBH=20, 
Brp=20, and Futsch=10. (K) Live imaging of synaptopods through the cuticle of intact 
Tdc2>mCD8-GFP larvae before and after starvation, showing the formation of 
varicosities (arrows) on top of synaptopods after starvation. Calibration bar is 10 µm for 
A-C, 22µm for D, 8.5µm for E, 2.5 µm for F-J, 12 µm for K.  
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Figure 2-3 
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Figure 2-3. Electrical activity and octopamine regulate the extension of synaptopods.  
(A, B) Live imaging of synaptopods before and after stimulation with (A) high K+, or (B) 
octopamine, in Tdc2>mCD8-GFP larvae. (C) Net increase in synaptopod number, 
approximately 2 hr after the indicated K+ or ChR2 stimulation paradigms (see Materials 
& Methods for details; N= 8,10,10,11). (D) Number of natural synaptopods in 
Tdc2>mCD8-GFP (WT control), and indicated genotypes (N=31,11,31). (E) Net increase 
in synaptopod number in Tdc2>mCD8-GFP control (no drug) and preparations exposed 
to the indicated drugs (N=11,13,8,18); control= no drug. (F) Net increase in the number 
of synaptopods in response to different concentrations of octopamine in Tdc2>GFP 
larvae (N=11,7,9,11). (G) Net increase in synaptopod number at subthreshold 
concentration of octopamine or K+ depolarization in the presence of 0.1 mM Ca++ (sub-
Ca++) in Tdc2>mCD8-GFP larvae (N=8,10,11,11,13,18,13). (H) Number of type II 
boutons at muscle 12 (A3) of 3rd-instar larvae in the indicated genotypes 
(N=16,10,15,14,12,6); wild-type= Canton-S. (I) Percentage increase in locomotor speed 
in response to food deprivation in the indicated genotypes (N=31,20,34,18,25); WT 
control= Canton-S. Calibration bar is 7 µm in A, B. Error bars represent SEM. 
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Figure 2-4 
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Figure 2-4. Innervation and maintenance of type II arbors depends on activity. (A, B, E-
H) NMJs at muscles 12 and 13 in preparations expressing mCD8-GFP in octopamine 
neurons and either double labeled with (A, B) anti-GFP and anti-HRP antibodies or (E-
H) anti-HRP and anti-TBH antibodies in (A) Tdc2>mCD8-GFP, (B) Tdc2>mCD8-GFP, 
Kir2.1, (E, G) wild type, and (F, H) Tdc2>Kir2.1 at the (A, B) third, (E, F) first, and (G, I) 
2nd-instar larval stage. Arrows point to type II boutons. (M) Percentage of intact, broken 
or absent (denervated) type II NMJs in Tdc2>Kir2.1, TubP-Gal80ts (Kir2.1-type II, 
Gal80ts) shifted to 29˚C at the indicated stages (N=25,24,46,22). (C, D) Type II 
motorneuron axons labeled with anti-GFP and anti-HRP (C) emerging from the CNS at 
the segmental nerves (arrows) and (D) terminating close to the NMJ (arrow) in GFP, 
Kir2.1-type II preparations stained with antibodies to HRP and GFP. (I-L) 3rd-instar type 
II NMJs from Kir2.1-type II, Gal80ts shifted to 29˚C at the stages indicated in the time 
scale at the top of each panel, double stained with anti-HRP and anti-TBH. Arrows point 
to breaks in the arbors or debris. Calibration bar is 24 µm in A-B, 12 µm in D, E-H, 38 
µm in C, and 10 µm in I-L. 
 
74 
 
  
 
Figure 2-5 
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Figure 2-5. Synaptopod extension is regulated by the cAMP pathway, and requires new 
protein synthesis, and CREB. (A-C) Live imaging of synaptopods (arrows) in (A) 
Tdc2>mCD8-GFP (WT control), (B) dncM14, Tdc2>mCD8-GFP, and (C) Tdc2>mCD8-
GFP, PACα before and after light stimulation. (D) Number of natural synaptopods in the 
indicated genotypes (N=175,21,11,8,17,11,24,11). (E-G) Net increase in synaptopod 
number (E) in preparations expressing PACα in wild type and tbh mutant background 
and subjected to the indicated light paradigms (N=10,12,12,11,12), (F) upon application 
of octopamine (OA) in the indicated genotypes (N=11,13,10,11,12,8) and (G) in 
Tdc2>mCD8-GFP preparations treated with actinomycin or cycloheximide, or expressing 
Tdc2>CREBdn and exposed to octopamine as indicated (N=11,13,18,11,13; see 
Materials & Methods for details of PACα and octopamine stimulation paradigms). (H) 
Locomotor speed of the indicated genotypes (N=31,18,15,21,15). (I) Percentage 
increase in locomotor speed in response to food deprivation in the indicated genotypes 
(N= 26,18,15,21,15). Calibration Bar in A-C is 14 µm. Error bars represent SEM. 
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Figure 2-6 
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Figure 2-6.  Presynaptic Octß2R autoreceptors, but not OAMB, regulate the growth of 
type II arbors. (A) Number of natural synaptopods in the indicated genotypes 
(N=175,12,13,25,14); WT control= Tdc2>mCD8-GFP. (B) Number of type II boutons in 
the indicated genotypes (N=16,12,16,16,15,11,11,10,12,12,13,12); WT control= Canton-
S; typeII driver control=Tdc2>Dcr; Octß2R-RNAi –typeII=Tdc2>Dcr, Octß2R-RNAi. (C) 
Net increase in the number of synaptopods in the indicated conditions and genotypes 
(N=11,13,11,10,12,11,14; WT control= Tdc2>mCD8-GFP). (D) Percentage increase in 
locomotor speed in the indicated genotypes in response to food deprivation 
(N=26,16,13,15,13,17,15,13,13,15); (E) Locomotor speed in the indicated genotypes 
(N=31,20,17,17,15,18,17,13,13,17). For (D, E), WT control= Canton-S; type II driver 
control= Tdc2>Dcr; type I+II driver control= C380>Dcr; muscle driver control= C57>Dcr; 
Octß2R-RNAi-type II= Tdc2>Dcr, Octß2R-RNAi; Octß2R-RNAi-type II+II= C380>Dcr, 
Octß2R-RNAi; Octß2R-RNAi-muscle= C57>Dcr, Octß2R-RNAi. Error bars represent 
SEM. 
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Figure 2-7 
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Figure 2-7. Type II motorneurons regulate the growth of type I arbors. (A, B) Number of 
type I boutons at muscle 6 and 7 (A3) in 3rd-instar larvae (A) upon eliminating either type 
II motorneurons, or octopamine production from type II motorneurons 
(N=12,17,21,18,20,13), and (B) in larvae with decreased Octß2R levels 
(N=12,36,17,18,12,13,11). WT control in A, B= Canton-S. Error bars represent SEM. 
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Supplemental Figure 2-1 
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Supplemental Figure 2-1.  Hid ablation of octopamine neurons. Larval preparations 
labeled with anti-HRP and anti-GFP of either (A, B) NMJs at muscle 12 and 13 or (C, D) 
larval CNS. (A, C) Control animals expressing Tdc2>mCD8GFP and (B, D) animals 
expressing Tdc2>Hid.  The lack of GFP signal in (B, D) demonstrates the complete loss 
of octopamine neurons. Calibration bar is 40 µm for A, B, and 50 µm for C, D.  
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Supplemental Figure 2-2 
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Supplemental Figure 2-2.  Imaging of synaptopods and their fate during larval 
development. (A) Time-lapse imaging of an NMJ in 1st, 2nd, and 3rd instar from an intact 
larva, showing synaptopods maturing into branches (arrows and arrowheads). (B-F) 
protein localization in maturing synaptopods in preparations triple labeled with anti-GFP, 
anti-TBH and antibodies to (B) FasII, (C, D) Syt1, (E) Brp, and (F) Futsch. Arrows point 
to sites of protein localization at synaptopods or newly formed varicosities. Calibration 
bar is 30 µm for A and 10 µm for B-F. 
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Supplemental Figure 2-3 
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Supplemental Figure 2-3.  Tdc2- and TBH-expressing neurons in the CNS and at the 
NMJ.  (A) Octopamine biosynthetic pathway. (B, C) Larval NMJs at muscle 12 labeled 
with anti-HRP and anti-TBH in (B) wild-type and (C) tbh mutants. (D-F) Larval CNS 
preparations double labeled with anti-TBH and anti-GFP from Tdc2>mCD8-GFP larvae 
in (D) wild-type and (F) tbh mutant. (E) High magnification view of the neuropil of wild-
type. Calibration bar is 15 µm for B, C, E, and 70 µm for D, F. 
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Supplemental Figure 2-4 
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Supplemental Figure 2-4.  GluRIIA immunoreactivity around type II boutons, and 
quantification of branch-points in genotypes with altered synaptopod numbers.  (A) Wild-
type type II arbor labeled with anti-GluRIIA, anti-HRP, and anti-TBH. (B) Quantification 
of type II branch-points on muscle 12. For (B) N is 14, 10, 13, 26 respectively. 
Calibration bar is 10 µm. 
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Supplemental Figure 2-5 
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Supplemental Figure 2-5.  Expression of ShiDNts in octopamine arbors.  Images of 3rd 
instar larval NMJs from larvae reared at 29oC labeled with anti-HRP and anti-TBH at (A-
D,G-H) muscle 12 and (E,F) muscle 13. (A,C,E,G) UAS-ShiDNts without Gal4 driver; 
(B,D,F,H) Tdc2>ShiDNts animals. Abnormal phenotypes include (B) shortened arbors, 
enlarged boutons with fragmented TBH signals, (D) strongly reduced innervation and 
lack of TBH signal, (F) thinned (arrowhead), shortened arbors, enlarged boutons (arrow) 
and lack of TBH signal, (H) thinned arbors and lack of TBH signals (missing arrows in 
H2). Calibration bar is 43 µm for A-F, 20 µm for G, H. 
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Supplemental Figure 2-6 
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Supplemental Figure 2-6.  Expression of Octβ2R in CNS and body wall muscles, 
efficacy of Octβ2R-RNAi and muscle size. (A) PCR amplifications from +RT (with 
reverse transcriptase) and –RT (without reverse transcriptase) of wild-type cDNA 
synthesized from either dissected brains or body wall muscles. Numbers to the left of 
the gel are in base pairs. (B) Effectiveness of the Octβ2R-RNAi transgene demonstrated 
by semi-quantitative RT-PCR. Numbers represent number of PCR amplification rounds. 
Control = UAS-Octβ2R-RNAi without Gal4 driver, RNAi= C380>Octβ2R-RNAi. GAPDH 
is used as a cDNA loading control. (C) Muscle area in indicated phenotypes. N= 12, 10, 
10, 10, 7, 10, 10, 10, 10, 10, 10, 10, 10, 10, 10 respectively. 
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Supplemental Figure 2-7 
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Supplemental Figure 2-7.  Expression pattern of BG439-Gal4.  3rd-instar larval NMJs 
from muscle 13 of segment A4 of BG439>mCD8-GFP animals co-labeled with anti-HRP 
and anti-GFP. Calibration bar is 27 µm. 
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Supplemental Figure 2-8 
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Supplemental Figure 2-8.  Model and cartoon of different motorneuron innervations. 
(A) Model of the autoregulatory mechanism in type II arbor growth and its influence on 
type I arbor growth (see text for details). (B) Cartoon depicting different modes of body-
wall muscle innervation by different motorneuron types (see text for details). 
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Supplemental Movie 1 (20K) 
Dynamics of natural synaptopods at type II arbors. 
http://www.nature.com/neuro/journal/v14/n2/extref/nn.2716-S2.mov 
 
Supplemental Movie 2 (256K) 
Synaptopods develop ball-shaped varicosities. 
http://www.nature.com/neuro/journal/v14/n2/extref/nn.2716-S3.mov 
 
Supplemental Movie 3 (112K) 
Secondary synaptopod formation on a varicosity. 
http://www.nature.com/neuro/journal/v14/n2/extref/nn.2716-S4.mov 
 
Supplemental Movie 4 (1M) 
Induction of synaptopod formation upon acute increase in cAMP levels. 
http://www.nature.com/neuro/journal/v14/n2/extref/nn.2716-S5.mov 
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ABSTRACT 
Adrenergic receptors and their ligands are important regulators of synaptic plasticity 
and metaplasticity. However, the development and plasticity of the aminergic terminals 
for these catecholamines are poorly understood. Octopamine, the invertebrate homolog 
of mammalian adrenaline or noradrenaline, plays important roles in modulating behavior 
and synaptic functions. We previously demonstrated the excitatory effect of octopamine 
on synaptic growth and locomotor activity during starvation through the autoreceptor 
Octß2R, resulting in a positive feedback mechanism. Here, we examined the role of 
another autoreceptor Octß1R. We found that Octß1R is inhibitory to arbor extension, 
likely through Goα. The fact that it has antagonistic downstream effects to Octß2R 
suggests that octopamine may offer a braking mechanism to its own positive feedback 
effect on synaptic growth. Interestingly, disruption of Octß1R or Goα function results in 
defective octopamine-induced neuronal outgrowth and starvation-induced larval 
locomotor increase, possibly due to near-saturated cAMP levels and outgrowth 
mechanism. These results demonstrate the dual action of octopamine on both synaptic 
growth and behavioral plasticity. 
99 
 
  
INTRODUCTION 
Synaptic plasticity plays an important role in behavioral changes of animals and 
their adaptations to the environment. Understanding the mechanism that mediates 
plasticity is therefore crucial. Adrenaline and noradrenaline are key regulators of 
synaptic plasticity and metaplasticity (Murchison et al., 2004; Hu et al., 2007; Kuzmiski 
et al., 2009). However, the development and plasticity of the aminergic neurons are 
poorly understood, and the underlying mechanisms of how adrenergic signals function 
at synapses are also unclear.  
Octopamine, the insect counterpart of mammalian adrenaline or noradrenaline 
activates receptors resembling adrenergic receptors (Balfanz et al. 2005). Octopamine 
is a powerful behavior modulator, involves in diverse physiological processes, such as 
appetitive behavior (Long and Murdock, 1983; Suo et al., 2006), aggression (Hoyer et 
al., 2008; Zhou et al., 2008) and synaptic function (Breen and Atwood, 1983).  
The Drosophila larval neuromuscular junction (NMJ) is a prime model system for 
studying synaptic plasticity (Griffith and Budnik, 2006). Apart from the type I 
motorneurons, which use glutamate as the primary excitatory neurotransmitter (Jan and 
Jan, 1976), the larval NMJ is also innervated by type II motorneurons containing 
octopamine (Monastirioti et al., 1995). Larval NMJs display several forms of functional 
and structural synaptic plasticity, such as continuous addition of varicosities during 
development to cope with the dramatic increase in muscle size (Schuster et al., 1996). 
This process depends on both retrograde and anterograde signals such as BMP 
(Marques and Zhang, 2006) and Wnt (Korkut and Budnik, 2009). Larval NMJs are 
sensitive to environmental changes for conditions such as deprivation of food, which 
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induces rapid increase in synaptic strength (Sigrist et al., 2003; Steinert et al., 2006). 
Furthermore, genetic and physiological manipulations that increase presynaptic activity 
promote synaptic expansion (Ataman et al., 2008; Budnik et al., 1990).  
In one of our previous studies, we investigated the significance of octopaminergic 
type II innervation at the NMJ (Koon et al., 2011). We demonstrated that octopaminergic 
terminals are critical for normal synaptic growth and larval foraging behavior. 
Octopamine, which is present in type II terminals, is secreted in an activity-dependent 
manner during starvation. Octopamine binds to autoreceptor Octß2R and activates a 
cAMP second messenger pathway that leads to CREB activation and transcription of 
synaptic proteins, which in turn allows the extension of new type II endings that we 
termed “synaptopods”. Type II innervation also regulated the plasticity of glutamatergic 
type I motorneurons through Octß2Rs expressed in these neurons. However, activation 
of this feed forward loop could eventually lead to exponential increase of the synaptic 
growth and excitation, which is undesirable and unsustainable. To prevent excessive 
growth, a braking mechanism is necessary to reset the system.  
In this study, we sought an inhibitory octopamine receptor that could play a role in 
this braking mechanism. We found that octopamine receptor Octß1R (also called OA2), 
which is also present in motorneurons, is inhibitory to synaptic growth. Octß1R likely 
interacts with the inhibitory G-protein Goα, which upon activation, suppresses cAMP 
production by adenylate cyclase. Abolishing Octß1R function or disrupting Goα function 
leads to synaptic overgrowth in both type I and type II motorneurons in a cell-
autonomous manner. In addition, we demonstrate a genetic interaction between Octß1R 
and Goα, suggesting that the two molecules functions in the same pathway. The 
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synaptic overgrowth in octß1r mutants is likely due to near-saturation levels of cAMP, 
since it can be fully suppressed by disrupting cAMP production using either an 
adenylate cyclase mutation (rut2080) or by overexpressing the phosphodiesterase (Dnc). 
Interestingly, disruption of Octß1R or Goα functions in type II motorneurons alone 
results in defective octopamine-induced synaptopods. This is possibly due to saturation 
of the system, since octß1R animals already have an overgrowth phenotype, and 
forskolin application fails to induce more synaptopods on their type II arbors. 
Furthermore, disrupting Octß1R or Goα functions in type II alone is sufficient to disrupt 
starvation-induced locomotor increase in larvae. These results are consistent with our 
previous findings that synaptic plasticity in type II terminals is critical for this type of 
behavioral plasticity. 
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RESULTS 
Octß1R receptors are present in motorneurons 
We have recently demonstrated that at the larval NMJ, octopamine-containing 
synaptic terminals (type II terminals) undergo structural changes in response to 
behavioral states that induce an increase in locomotion (Koon et al., 2011). 
Underlying this structural change is the activation of a positive feedback mechanism, 
in which octopamine release by type II synapses activates Octß2R autoreceptors 
(Koon et al., 2011). In turn, Octß2R turns on a cAMP- and CREB-dependent 
signaling cascade at type II endings, which induces synaptic growth. This positive 
control mechanism does not only promote the growth of type II synaptic boutons, but 
also functions in a paracrine fashion to stimulate the growth of type I boutons (Koon 
et al., 2011), primary mediators of excitatory transmission at the NMJ. 
Analysis of Gal4 transcriptional reporters, 19H07-Gal4, 21E03-Gal4, 20C11-Gal4, 
and 20E11-Gal4, generated by fusing Gal4 to four different intronic regions of the 
Octß1R (a.k.a OA2) octopamine receptor in Drosophila (Pfeiffer et al., 2008), 
suggested that like Octß2R, Octß1R is also expressed in motorneurons (Fig. 3-1A-
E). mCD8-GFP reporter signal could be observed in all bouton types, including type I 
and type II boutons (Fig. 3-1A-D). To determine if Octß2R and Octß1R serve 
redundant roles at the NMJ, we generated an octß1r mutant by FRT mediated 
recombination of two P-element insertions (PBac [WH]oa2[f02819] and 
PBac[WH]w[f06195]) (Fig. 3-1E). Analysis of the mutant strain demonstrated that 
most of the octß1r coding region had been removed (Fig. S3-1), excluding a 
fragment encompassing the 5’ UTR and the first exon of octß1r, which is predicted to 
encode the N-terminal extracellular domain, the first transmembrane domain, and 4 
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amino acids of the first intracellular loop of the receptor. However, RT-PCR 
demonstrated the virtual absence of the predicted transcript fragment (Fig. 3-1F), 
suggesting that octß1r is likely a null mutant.   
 
Octß1R receptors are negative regulators of synaptic growth 
 We previously demonstrated that type II NMJs expand by extending natural 
synaptopods, motile filopodia-like extensions observed during the expansion of type 
II terminals through larval development (Koon et al., 2011). Further, we found that 
the number of natural synaptopods is reduced in octß2r mutants due to an 
autonomous function of Octß2R in these neurons (Koon et al., 2011). To determine if 
Octß1R receptors had a redundant role in type II boutons, we examined natural 
synaptopods in octß1r mutants by expressing mCD8-GFP in type II motorneurons 
using Tdc2-Gal4 (Cole et al., 2005). Notably, the number of natural synaptopods was 
substantially increased in this mutant (Fig. 3-2A, B, C), in complete opposition to the 
phenotype found in octß2r mutants. A similar phenotype was found when Octß1R 
receptor was downregulated in octopaminergic neurons alone by expressing 
Octß1R-RNAi in octopaminergic neurons (Fig. 3-2C), suggesting a cell-autonomous 
function of the receptor. Thus, Octß1R receptors appear to negatively regulate the 
formation of synaptopods at type II terminals. Consistent with this role, the number of 
type II boutons was also increased both in octß1r mutants and in larvae expressing 
Octß1R-RNAi in octopaminergic neurons (Fig. 3-2D, E, F). 
 
 
104 
 
  
The inhibitory function of Octß1R is likely mediated by Goα 
Synaptopod formation is downstream of elevated cAMP levels, mediated by 
octopamine-dependent activation of Octß2Rs (Koon et al., 2011) a G-protein-
coupled receptor. Octß1R is also predicted to function as a G-protein-coupled 
receptor (Balfanz et al., 2005; Evans and Maqueira, 2005). Therefore we wondered 
whether the negative regulation of type II synaptic growth by Octß1R could be 
mediated through activation of G-protein inhibitory subunits, such as Goα or Giα 
(Johnston et al., 2003; El-Armouche et al., 2003). This hypothesis was first 
examined by bath applying pertussis toxin (PTX), which in Drosophila specifically 
inhibits Goα (Thambi et al., 1989), and determining its consequences on 
octopamine-dependent synaptopod formation. As previously reported, application of 
10 µM octopamine to wild type control NMJs resulted in a significant increase in the 
number of synaptopods (Fig. 3-3A, C). Application of 10 µM octopamine in 
conjunction with 1.5µg/ml PTX dramatically enhanced this effect (Fig. 3-3B, C). This 
is consistent with the idea that activation of Goα partially inhibits octopamine-
dependent synaptopod formation. In support of this interpretation, the number of 
natural synaptopods was substantially increased in larvae expressing UAS-PTX in 
octopamine neurons throughout larval development (Fig. 3-3D, E, G). 
 To corroborate an involvement of Goα in inhibiting synaptopod formation, we 
expressed two different Go-RNAi constructs in octopaminergic neurons, Go-RNAi1 
and Go-RNAi2, and examined the number of natural synaptopods at type II arbors in 
3rd instar larvae. In agreement with our model, downregulating Goα by either RNAi 
resulted in significant increase in the number of natural synaptopods (Fig. 3-3F, G). 
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In contrast, downregulating Giα by using two different Gi-RNAi constructs was 
without effect (Fig. 3-3G). 
 Since synaptopods are precursors of type II boutons (Koon et al., 2011), we also 
expected that inhibiting or downregulating Goα function should result in abnormal 
type II bouton growth. Indeed, expressing PTX or the two Go-RNAi constructs in 
octopaminergic neurons resulted in significant increase in the number of type II 
boutons (Fig. 3-3H).  
To further test the hypothesis that Octß1R mediates inhibition via Goα, we looked 
for a genetic interaction between the two molecules. We found that heterozygous 
octß1R and goα (go[007]) mutations result in a synergistic effect of synaptic 
overgrowth in both natural synaptopods and type II boutons (Fig. 3-3I,J). Together, 
these results suggest that Octß1R receptors inhibit the growth of type II endings via 
inhibitory G-protein Goα. Disrupting Goα or Octß1R leads to increased cAMP 
production, which in turn results in increased synaptopods and boutons.  
 
Octß1R function is antagonized by changes in cAMP levels but its function is 
partially independent from Octß2R 
 If Octß1R receptors inhibit cAMP production, consistent with the above model, 
then decreasing cAMP levels by an independent approach should suppress the 
effects of octß1r mutants. This hypothesis was tested by examining the effect of 
synaptopod formation in animals lacking the adenylate cyclase, Rutabaga (Rut), or 
by overexpressing the phosphodiesterase, Dunce (Dnc) in the octß1r mutant 
background. Consistent with the above hypothesis, both conditions prevented the 
increase in synaptopods elicited by mutations in octß1r (Fig. 3-4A). Similarly, they 
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also prevented the increase in the number of type II boutons (Fig. 3-4B). Since the 
resulting phenotypes are no difference from rut alone or overexpressing Dnc alone, it 
is likely that Rut and Dnc are downstream components of the same pathway.  
 We previously demonstrated that Octß2R receptors promote the formation of 
synaptopods and the expansion of type II terminals by facilitating cAMP production 
(Koon et al., 2011). However, other G-protein-coupled receptors, in addition to 
Octß2R receptors, may also regulate cAMP levels. To determine if Octß1R receptors 
function by inhibiting the action of Octß2R receptors, we generated octß1r;octß2r  
double mutants by recombination on the third chromosome. The double mutation 
was verified by genomic PCR (data not shown). If Octß1R and Octß2R antagonize 
each other, then null mutations in octß2r should completely suppress the effect of 
mutations in octß1r in synaptopod formation. However, we found that in the double 
mutant, the number of natural synaptopods was intermediate, and significantly 
different between the reduced number of natural synaptopods in octß2r mutants and 
the increased number of natural synaptopods in octß1r mutants (Fig. 3-4C). Similar 
results were obtained in the number of type II boutons (Fig.3-4D). These 
observations suggest that Octß1R receptors function, at least in part, independently 
from Octß2R receptors. 
 
octß1r mutants likely have near-saturated levels of cAMP 
We also examined the effect of octopamine application in synaptopod formation 
at type II endings in octß1r mutants and in larvae expressing Go-RNAi, Gi-RNAi or 
UAS-PTX in octopaminergic neurons. No response to octopamine was observed at 
type II boutons in octß1r mutants, when Goα was downregulated, or when PTX was 
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expressed throughout larval development in octopaminergic neurons (Fig. 3-5A). In 
contrast, the response to octopamine when Giα was downregulated was normal 
(Fig. 3-5A). A likely explanation for the lack of response to octopamine in octß1r 
mutants or when expressing either Go-RNAi or UAS-PTX, is that in these conditions 
the number of natural synaptopods is substantially increased (Fig. 3-4A). It is 
possible that synaptopod formation has reached saturation in these animals, which 
would occlude a further increase in number by octopamine application. This 
interpretation is supported by studies of dunce mutants. Dunce encodes a cAMP-
specific phosphodiesterase, and thus when mutated it results in significant increase 
in cAMP levels and thus a drastic increase in the number of natural synaptopods, 
likely to saturation (Koon et al. 2011). As in the above strains, in dnc mutants there 
was not significant response to octopamine (Fig. 3-5A).  
If it is true that octß1r has near-saturated levels of cAMP, then increasing cAMP 
levels in these mutants should not result in further increase of synaptopods. To test 
this hypothesis, we bath-applied opened living larval preparations of control animals 
and octß1r mutants in 10 µM forskolin to increase their cellular cAMP. In control 
animals, forskolin resulted in an increase of synaptopods similar to that produced by 
octopamine. In contrast, this increase is abolished in octß1r mutants (Fig. 3-5B). In 
our previous study, we demonstrated that octß2r mutants are also defective in 
octopamine-induced synaptopod increase, similar to that of octß1r mutants (Koon et 
al., 2011). However, octß2r mutants have an undergrowth phenotype, which is 
opposite to that of octß1r. In addition, in contrast to octß1r mutants, octß2r mutants 
have normal response to forskolin. These results further support the notion that 
octß1r mutants have near-saturated levels of cAMP.  
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octß1r mutants are defective in starvation-induced locomotor increase 
Since octß1r mutants have near-saturated levels of cAMP, Octß2R in these 
mutants apparently cannot further increase cAMP in response to octopamine. In our 
previous study, we showed that the autoregulatory mechanism of octopamine 
neurons through Octß2R is necessary for normal locomotor increase in response to 
starvation (Koon et al., 2011). We therefore hypothesized that octß1r may have 
similar behavioral deficits as those of octß2r. As we expected, octß1r failed to 
respond to starvation by increasing locomotor speed (Fig. 3-5C). The same defect 
was also observed in animals expressing UAS-PTX or Go-RNAi1 in octopaminergic 
neurons, but not Gi-RNAi1 (Fig. 3-5C). This result indicates that defective Octß1R 
signaling likely leads to defective Octß2R signaling, which is required for normal 
starvation-induced behavior in larva. It also confirms our previous findings that 
octopaminergic signaling in octopaminergic neurons is necessary for this type of 
behavioral plasticity. Interestingly, octß1r; octß2r double mutants are still defective in 
the starvation response (Fig. 3-5C), even though they have wild type levels of 
natural synaptopods and boutons. This is probably because they still lack the 
excitatory Octß2R, which is the receptor necessary for this behavioral response.  
 
Octß1R receptors cell-autonomously inhibit type I synaptic growth 
 We have previously demonstrated that the undergrowth of type II boutons result 
in parallel defects in the growth of type I boutons, implicating type II terminals 
regulating type I growth (Koon et al., 2011). Therefore, we seek to determine if 
overgrowth of type II would result in overgrowth of type I. We examined type I bouton 
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numbers in octß1r mutants and animals with disrupted Goα functions in type II 
motorneurons by expressing UAS-PTX or Go-RNAi. octß1r indeed has a type I 
overgrowth phenotype (Fig. 3-6A, B). But disrupting Goα functions in type II alone 
did not result in increased type I boutons (Fig. 3-6B, C). Nevertheless, hampering 
Goα functions in type I & II using a type I- & II-specific driver (C380-Gal4) did result 
in increase of type I boutons. This suggests that Octß1R functions in a cell-
autonomous fashion at type I boutons to regulate synaptic growth, similar to our 
previous finding with Octß2R, but in the opposite manner (Koon et al., 2011). In 
addition, similar to our findings in synaptopods and type II boutons, the genetic 
interaction between Octß1R and Goα was also observed in type I, suggesting that 
the Octß1R inhibits synaptic growth through Goα in these terminals as well, similar 
to the mechanism in type II. 
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DISCUSSION 
 
We previously demonstrated that octopamine regulates synaptic and behavioral 
plasticity through an autoregulatory positive feedback mechanism involving Octß2R that 
promotes both type I and type II outgrowth (Koon et al., 2011). In this study, we have 
identified an octopamine receptor, Octß1R, with antagonist functions to Octß2R, which 
may serve to break the positive feedback mechanism. We demonstrated that this 
receptor inhibits the cAMP pathway via the inhibitory G-protein Goα. Loss of Octß1R or 
Goα function results in synaptic overgrowth in type I and type II motorneurons in a cell-
autonomous manner. Defective Octß1R signaling apparently results in near-saturation 
of cAMP levels, and this obscures the function of Octß2R of increasing cAMP. Thus, the 
loss of Octß1R function results in insensitivity of octopaminergic neurons to octopamine 
stimulation. This in turn abolishes starvation-induced behavioral changes that require 
Octß2R signaling. 
Octopamine receptors have been shown to elicit intracellular Ca2+ and/or cAMP 
increase (Han et al, 1998; Balfanz et al., 2005). OAMB, the α-adrenergic-like receptor in 
Drosophila, has been implicated to function via Ca2+ signaling in the Drosophila oviduct 
(Lee et al., 2009). Interestingly, OAMB was not found to be expressed in the oviduct 
muscle cells, but in the oviduct epithelium (Lee et al., 2009). Since octopamine induces 
relaxation in the dissected oviduct, it was suggested that another octopamine receptor 
could be present in the oviduct muscles, eliciting an inhibitory effect on cAMP production 
(Lee et al., 2009). Our work here demonstrates that the inhibitory octopamine receptor 
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Octß1R is capable of decreasing cAMP levels in motorneurons. It is possible that 
Octß1R is also expressed in oviduct muscle cells, mediating muscle relaxation.  
In apparent contradiction to our findings, a previous study has shown that Octß1R 
(a.k.a. OA2) is capable of increasing cAMP (Balfanz et al., 2005). In this study, HEK293 
cells transfected with Octß1R were exposed to different concentrations of octopamine 
and assayed for changes in cAMP levels (Balfanz et al., 1005). It was found that Octß1R 
enhanced cAMP synthesis. A likely problem of the above experimental design is that the 
overexpression of Octß1R might alter its binding to G-proteins. For instance, mammalian 
ß2-adrenergic receptors are known to couple to both Gs and Gi/o proteins (Xiao, 2001). 
The disruption of inhibitory G-proteins by pertussis toxin significantly enhances ß2-
adrenergic receptors-mediated contractile response in mammalian cardiomyocytes, 
suggesting that this receptor is capable of pairing with inhibitory G-protein Gi or Go 
(Xiao et al., 1995). However, overexpression of ß2-adrenergic receptors in the murine 
heart constitutively couples the receptor to Gs (Milano et al., 1994; Bond et al., 1995) 
but not to Gi/o protein. High or medium overexpression of ß2-adrenergic receptors in 
transgenic mice was demonstrated to co-precipitate with Gs but not Gi/o proteins in the 
absence of agonist (Gurdal et al., 1997). Thus, overexpression might significantly alter 
the normal physiological condition of these receptors. In addition, HEK293 cells originate 
from human embryonic kidneys, whereas Octß1R is from Drosophila. The coupling of an 
insect octopamine receptor to mammalian G-proteins does raise questions of 
physiological relevance. 
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Goα (a.k.a Brokenheart) is expressed in the nervous system of Drosophila, with 
markedly increased during the development of axonal tracts (Guillen et al., 1991). The 
level of Goα proteins is altered in memory mutants including dunce and rutabaga 
(Guillen et al., 1990). Furthermore, Goα was found to be necessary in associative 
learning (Ferris et al., 2006). When PTX is overexpressed in the mushroom bodies of 
adult Drosophila, memory formation is severely disrupted (Ferris et al., 2006), 
suggesting a role of Goα in synaptic plasticity. However, as the name “Brokenheart” 
suggests, homozygous goα mutants are lethal due to defective development of the heart 
(Fremion et al., 1999), rendering this mutant difficult to be used in studies of the larval 
NMJ. Moreover, overexpression of inhibitory G-proteins has been shown to sequester 
available Gß and Gγ subunits, resulting in undesired downregulation of other G-protein 
signaling (Katanayeva et al., 2010). Therefore, overexpression is not a desirable method 
to study the function of Goα. Fortunately, the use of pertussis toxin and multiple RNAi 
constructs allowed us to downregulate Goα functions cell-specifically, developmentally 
or acutely in the larva, permitting us to examine synaptic overgrowth. Moreover, genetic 
interaction was also found between heterozygous octß1r and heterozygous goα 
mutations, indicating that the two molecules act in the same signaling pathway to inhibit 
synaptic growth. These results provided strong evidence of Goα’s involvement in 
synaptic plasticity. 
 
In summary, our studies reveal that, apart from excitation, octopamine can also 
elicit inhibition on synaptic growth. Having the flexibility to convert from excitatory effects 
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to inhibitory effects allows octopamine to exert a broader level of control over synaptic 
functions and behavior. 
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MATERIALS AND METHODS 
Fly strains. Flies were reared in standard Drosophila medium at 25°C except where 
indicated. Animals used in RNAi experiments were reared at 29oC to increase 
knockdown efficiency, but were incubated at 25°C for 1 hour prior to experiments. The 
following stocks were used: the wild-type strain Canton-S (CS), Tdc2-Gal4 (Bloomington 
Stock Center), 19H07-Gal4, 20C11-Gal4, 20E11-Gal4, 21E03-Gal4 (Pfeiffer et al., 
2008), UAS-mCD8-GFP (Bloomington), UAS-PTX (Ferris et al., 2006), y dncM14 cv v f 
(Bloomington), UAS-Dnc (remobilized to the 2nd chromosome) (Cheung et al., 1999), 
rut2080 (Bloomington), goα [007] (Fremion et al., 1999), UAS-Dcr2 (Bloomington), 
Pbac{WH}oa2[f02819] (Bloomington), Pbac{WH}w[f06195] (Harvard Exelixis), 
Pbac{WH}Octß2R[f05679] (Bloomington), w[1118]; Df(3R)Exel6191, P{w[+mC]=XP-
U}Exel6191 (Bloomington), C380-Gal4 (Budnik et al., 1996), UAS-Octß1R-RNAi 
(110537; Vienna Drosophila RNAi Center), UAS-G(o)-RNAi (110552 & 19124; Vienna 
Drosophila RNAi Center) (110552 is Go-RNAi1 and 19124 is Go-RNAi2), UAS-G(i)-
RNAi (28510; Vienna Drosophila RNAi Center. JF01608; Transgenic RNAi Project, 
Harvard Medical School) (28510 is Gi-RNAi1 and JF01608 is Gi-RNAi2). 
Generation and analysis of octβ1R mutants. octβ1r mutants were generated using 
Pbac{WH}oa2[f02819] and Pbac{WH}w[f06195] which contain piggyback-based 
transposons in the same orientation on the third chromosome. A heat-shock Flipase was 
crossed into the first chromosome to induce recombination between the two 
transposons and to excise the flanked DNA. The heat-shock processes were performed 
at 37oC for 30 min during 1st instar and 2nd instar larval stages respectively. The heat-
shock Flipase was then crossed out of the first chromosome to obtain a stable mutant. 
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Genomic PCR was performed to verify the desired deletion. Primers used to verify the 
deletion were GTCATGCGGCACCGGAAATTG (against genomic DNA) paired with 
CCTCGATATACAGACCGATAAAAC (WH3’); and CTAAAGTGCATTGCACCTGG (against genomic 
DNA) paired with TCCAAGCGGCGACTGAGATG (WH5’). Negative control primers (against 
Octβ1R genomic sequence) to verify deletion were ACAGGAGCGTCTGGTGTAC paired with 
CGGAGTGATGCAACTATCGC, TGTCAAGCGCACAGAACTC paired with 
GCGTTGGTTGGTTCCAAGG, and AGTGCTGTACAGTAGCGAGC paired with 
CCTGACTCCATGACACCTAAATATG. RT-PCR was performed by extracting total mRNA from 
dissected larval body wall muscles and larval brains using a combination of Trizol 
(Invitrogen) and the RNeasy kit (Qiagen). Synthesis of cDNA for +RT reactions was 
performed using the Superscript III kit (Invitrogen), where –RT reactions lacked reverse 
transcriptase. The +RT and –RT reactions were then used for PCR using forward primer 
CCGCCTGGCAACGAGTAAC and reverse primer CTCGTCGATGAGCCCGTC. These primers 
were specifically designed to recognize all known splice variants of Octß1R, and across 
an exon-intron junction to avoid false signal from any contaminating genomic DNA.
Immunocytochemistry: Larval body-wall muscles were dissected and fixed for 15 
minutes in 4% paraformaldehyde. For tyramine-β-Hydroxylase (TBH) 
immunocytochemistry, samples were fixed in Bouin’s fixative. Antibodies and their 
concentrations were: anti-TBH 1:400 (Koon et al., 2011), anti-HRP-Dylite594 1:500 
(Jackson Immunoresearch). Secondary antibodies conjugated to either FITC or 
Dylite594 (Jackson) were used at a concentration of 1:200. Imaging of fixed 
preparations was described (Ataman et al., 2008). 
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Animal rearing conditions for synaptopod analysis: All animals used in synaptopod 
analysis carried a copy of Tdc2-Gal4 and a copy of UAS-CD8:GFP to visualize the type 
II terminals. Egg collection was done in standard 25 mm diameter 
cornmeal/agar/molasses food vials at 25oC with approximately 60% humidity. Larvae 
were grown at low density. Wandering late 3rd-instar larvae were used for experiments. 
Stimulation procedures and live imaging of dissected preparations: Synaptopods were 
imaged from live preparations as described in (Koon et al., 2011). For octopamine 
stimulation, larvae were dissected in HL3 saline (Stewart et al., 1994) containing 0.1 mM 
Ca2+ and preparations gently glued onto a custom-made glass imaging chamber using 
surgical glue. Then, identified NMJs were imaged on an Improvision spinning disc 
confocal microscope (PerkinElmer) with a C9100-13 Hamamatsu cooled EM-CCD 
camera and using a 40X; 1.2 NA objective, with a 2.4X optical zoom. After imaging for 
less than 30 min, animals were partially unglued to allow muscles to contract freely, and 
10 µM octopamine in HL3 containing 1.5 mM Ca2+ was then applied for 15 min followed 
by 5 x 15 min washes with 0.1 mM Ca2+ HL3 saline before imaging again. For 
experiments involving pertussis toxin (PTX) application, dissected living larval prep was 
pre-incubated in HL3 containing 0.1 mM Ca2+, 0.03% DMSO, 30 µM ATP and 1.5 µg/ml 
PTX (purchased from Sigma) for 2 hours. Then, HL3 containing 1.5 mM Ca2+, 10 µM 
octopamine, 0.03% DMSO, 30 µM ATP and 1.5 µg/ml PTX was applied for 15 min, 
followed by 5 x 15min washes with the pre-incubation HL3. Control animals were pre-
incubated, stimulated and washed in the same way but without PTX. 
Crawling assay and starvation assay: Details of crawling and starvation assays were 
described in (Koon et al., 2011). Synchronized mid 3rd-instar larvae were washed with 
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water, and individually loaded onto a 3% agar plate. Animals were allowed a pre-run of 
25 sec on the agar before manual recordings were made for 1 minute. Experiments 
were carried out in a 25˚C, 60% humidity behavioral room under red light. For starvation 
assay, larvae were maintained in food or food-free moisturized 35 mm Petri dishes for 2 
hrs, and then subjected to the crawling assay. N represents one animal. For RNAi 
experiments, food vials rearing animals at 29oC were incubated at 25oC for 1 hour prior 
to crawling assay or starvation assay. 
Quantification of boutons and synaptopod number: Type I boutons number was obtained 
at muscles 6 and 7 of abdominal segment A3, while type II bouton number was 
quantified at muscle 12 in A3. For muscle area measurements the muscle length and 
width was measured using an ocular scale bar. Measurements of synaptopod number 
were from muscles 12 of segment A4 in dissected preparations. Number of synaptopods 
in the histograms represents the total number of synaptopods per 100 µm of each arbor. 
Synaptopods were defined as such if they measured 0.5 µm or more. N represents 
number of NMJs. At most two NMJs were quantified per animal. 
Statistical analysis For comparisons between more than 2 sample groups an analysis of 
variance (ANOVA) with Tukey post-hoc test was performed. For pair-wise comparisons 
a Student t-test was used. Numbers in histograms represent mean± SEM. *** is p< = 
0.0001, ** is p< = 0.001, * is p<0.05. Unless otherwise noted, sample number (N) 
represents one synaptic arbor for anatomical measurements, or one animal for 
behavioral analyses. Statistical analysis for animals reared at 25oC and animals reared 
at 29oC are calculated separate. 
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Genotype abbreviations: Type II driver control is Tdc2/+. Type I+II driver control is C380-
Gal4/+. [transgene]-type II is Tdc2-Gal4>[transgene]. [transgene]-type I+II is C380-
Gal4>[transgene], unless otherwise indicated. 
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Figure 3-1 
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Figure 3-1. Expression patterns of Octß1R-Gal4 transcriptional reporters.  
(A-D) NMJs at muscle 12 of a third instar larva expressing mCD8-GFP using four 
different Octß1R-Gal4s generated from different intronic regions of the Octß1R locus. As 
shown by white arrows, (A)19H07-Gal4 has expression in type Ib and type II boutons, 
(B) 21E03-Gal4 – type Is and type II, (C) 20C11-Gal4 – type III, and (D) 20E11-Gal4 – 
type Ib and type III. Labeled with anti-HRP (A2, B2, C2, D2) and anti-GFP (A1, B1, C1, 
D1). Calibration bar is 23 µm. (E) Schematic diagram of the Octß1R locus showing the 
locations of different intronic regions used to generate the Gal4 transcriptional reporters 
(Pfeiffer et al., 2008). The diagram also shows the location of the two Pbac insertions 
used for generating the octß1r mutant. Orange = exon. Grey = non-coding UTRs. Thin 
black line = intron. (F) RT-PCR of whole wild type animals versus octß1r mutants. 
Minimal expression of the remaining 5’UTR and exon was detected in octß1r mutants. 
+RT: reverse transcription reactions with reverse transcriptase added; -RT: reverse 
transcriptase absent.  
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Figure 3-2 
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Figure 3-2. octß1r mutants have a synaptic overgrowth phenotype.  
(A) type II arbors of a control animal (B) type II arbors of an octß1r animal showing 
marked increase of synaptopods (white arrows). (C) Quantification of number of natural 
synaptopods per 100 µm arbor in octß1r mutants and animals expressing Octß1R-RNAi 
in type II motorneurons (N=175,13,21,10,11,25,17). NMJs at muscles 12 of a third instar 
larva of (D) wild type and (E) octß1r . Labeled with anti-HRP (red) and anti-TBH (green). 
(F) Quantification of the number of type II boutons on muscle 12 of the above animals 
(N=22,17,15,11,16,20,11). RT: Reared at 25oC. 29oC: Reared at 29oC. Animals used in 
RNAi experiments were reared at 29oC to increase knockdown efficiency. Calibration 
bar is 8 µm in (A,B) and 20 µm in (D,E). 
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Figure 3-3 
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Figure 3-3. Disruption of Goα phenocopies synaptic overgrowth of octß1r  
(A) Bath application of octopamine increases the number of synaptopods on type II 
arbors. (B) The presence of pertussis toxin (PTX) results in significantly higher increase 
of synaptopods by octopamine stimulation. (C) Quantification of the net increase of 
synaptopods in (A) and (B) per 100µm arbor (N=18,13,16). (D-F) Natural synaptopods 
in (D) control, (E) animals expressing PTX in type II, and (F) animals expressing Go-
RNAi1. (G) Quantification of natural synaptopods in animals expressing PTX, Go-RNAi 
or Gi-RNAi (N=175,1219,10,11,10). (H) Quantification of type II boutons in animals 
expressing PTX, Go-RNAi or Gi-RNAi (N=22,16,12,20,24,16,16,10,16). (I) Quantification 
of natural synaptopods of transheterozygotes of octß1r and goα (N=175,21,11,10,11), 
(J) Quantification of type II boutons of the animals in (I) (N=22,15,16,12,16). RT: Reared 
at 25oC. 29oC: Reared at 29oC. Animals used in RNAi experiments were reared at 29oC 
to increase knockdown efficiency. Calibration bar is 12 µm in (A,B,D-F). 
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Figure 3-4 
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Figure 3-4. Suppression of the overgrowth phenotype of octß1r by reducing cAMP. 
(A,B) rut mutation or overexpression of Dnc fully suppress the synaptic overgrowth 
phenotype, supporting the hypothesis that Rut and Dnc are downstream components of 
the Octß1R signaling pathway. (C,D) Octß1R and Octß2R appear to function partially 
independently. (A,C) Quantification of synaptopods. (B,D) Quantification of type II 
boutons. (N=175,21,24,13,14,13 in A. N=22,15,18,18,12,12 in B. N=175,13,21,12 in C. 
N=22,17,15,16 in D.) 
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Figure 3-5 
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Figure 3-5. octß1r mutation or disruption of Goα results in near-saturation levels of 
cAMP and defective starvation-induced behavior. (A) Bath application of octopamine 
increases synaptopods in control animals, but not in octß1r, dnc and animals expressing 
PTX or Go-RNAi. Net increase of synaptopods is quantified per 100um arbor 
(N=14,13,12,10,10,11,12,11,19,10). (B) Bath application of octopamine fail to increase 
synaptopods in both octß1r and octß2r, whereas bath application of forskolin increases 
synaptopods in octß2r but not in octß1r (N=14,13,11,10,12,13,11,13,10). (C) Percentage 
increase of larval crawling speed in response to 2 hr starvation in wild type, octß1r, 
octß2r, octß1r;octß2r double mutant, and animals expressing PTX, Go-RNAi or Gi-RNAi 
in octopaminergic neurons (N=26,16,16,15,16,16,16,16,17,13,19,16,16,17). RT: Reared 
at 25oC. 29oC: Reared at 29oC. Animals used in RNAi experiments were reared at 29oC 
to increase knockdown efficiency. 
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Figure 3-6 
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Figure 3-6. Octß1R regulates type I synaptic growth (A-B) NMJ at muscles 6/7 of 
segment A3 of (A) wild type and octß1r mutant, and (B) Go-RNAi/+ control and Go-
RNAi-Type I+II. octß1r and Go-RNAi-Type I+II have increased type I boutons comparing 
to their corresponding controls. Preparations labeled with anti-HRP. (C-D) Quantification 
of total type I bouton numbers from muscle 6/7 of segment A3. (C) Total bouton 
numbers of wild type, combinations of oct1ßr mutants, goα mutants and larvae with 
neuronal-specific expression of Pertussis toxin (PTX). octß1r and goα showed genetic 
interaction in the increase of type I boutons (N=18,15,16,16,12,18,14,14,16,12,14). (D) 
Total bouton numbers from controls and Go- or Gi-RNAi lines (N=15,14,12,16,12,16, 
11,16,16,12,14,10,12,16,16). RT: Reared at 25oC. 29oC: Reared at 29oC. Animals used 
in RNAi experiments were reared at 29oC to increase knockdown efficiency. Calibration 
bar is 10 µm in (A-B). 
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               Supplemental Figure 3-1 
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Supplemental Figure 3-1. Verification of octß1r mutant by genomic PCR Primer pair #1 
verifies the presence of Pbac[f02819]. Primer pair #2 is negative control for primer pair 
#1. Primer pair #3 verifies the presence of Pbac[f06195]. Primer pair #4 is negative 
control for primer pair #3. Primer pair #5, 6 and 7 verifies the presence of Octß1R. 
octß1r is positive for both #1 and #3, indicating a successful recombination event. It is 
negative for #5-7, indicating that the deleted Octß1R fragment is not present in the 
genome.
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CHAPTER 4 
 
General Discussion 
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 Aminergic modulation of synaptic and behavioral plasticity has been known for 
decades. However, the underlying mechanisms are still unclear. In fact, studies that 
successfully bridge across the role of aminergic regulation in synapses and behavior are 
sparse. A likely explanation is that the circuitry underlying behavioral modulation by 
aminergic signaling is still poorly defined. One might be able to identify a neural circuit 
responsible for a particular behavior and study how octopamine affects it, but the 
knowledge of this circuit might not have sufficient resolution or accessibility to 
investigate potential structural and functional changes elicited by aminergic modulation. 
On the other hand, one might be able to identify structural and functional changes 
elicited by biogenic amines at the cellular level in a preparation that allows detailed 
examination, but the isolation of this preparation might involve substantial damage to the 
animal, making it difficult to apply the knowledge obtained to the behaving animal. The 
research detailed in this thesis is a bold attempt to bridge across synaptic remodeling 
and behavioral changes elicited by aminergic modulation. The range and depth of this 
research is primarily due to the following advantages of our chosen preparation: (1) The 
accessibility and tractability of the Drosophila larval NMJ allowed us to perform studies 
with single synaptic bouton resolution in a defined population of synapses. Such 
resolution is not possible in other preparations involving fairly undefined population of 
synapses. (2) The simple layout of octopaminergic and glutamatergic neuronal terminals 
at specific muscles allowed us to carry studies of synaptic terminals with minimal 
interference from other synaptic terminals. (3) The transparency of the larval cuticle and 
muscles allowed us to trace and image the same NMJs of an intact animal during 
development from first to third instar larval stages. (4) The relatively simple behaviors of 
the Drosophila larva facilitated the establishment of clear relationships between 
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behavioral and synaptic changes in response to aminergic signaling. (5) The availability 
of powerful genetic tools and RNAi collections allowed us to conveniently manipulate 
and visualize neurons in vivo. 
 
Dual modes of octopamine signaling broaden the level of control 
At the Drosophila larval NMJ, three type II motorneurons per segment innervate 
most of the body wall muscles in that segment. This layout suggests that octopamine is 
likely to globally regulate plasticity, by tuning the excitability levels of multiple synapses 
in the entire body wall. Our observation that an excitatory and an inhibitory octopamine 
receptor are coexpressed in this system indicates that this global regulation can be 
tipped towards general excitation or inhibition. This dual mode of controlling excitability 
likely provides enhanced flexibility, allowing a broader level of control over synaptic 
functions. We unraveled the presence of an autoregulatory mechanism in 
octopaminergic neurons, which was dependent on both Octß1R and Octß2R receptors. 
Our data suggest that these receptors activate or inhibit cAMP production, regulating 
CREB-mediated protein synthesis and synaptic growth. This mechanism is necessary 
for normal locomotor increase during starvation. At the same time, octopamine also 
regulates glutamatergic neurons via the same receptors. This paracrine signaling is 
important for normal synaptic growth of glutamatergic neurons during development. 
 
Demonstration of structural plasticity mediated by starvation and octopamine 
While previous studies have demonstrated a relationship between octopamine 
signaling and starvation in the locust and in C. elegans (Davenport and Evans, 1981; 
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Suo et al., 2006), this relationship had not been well established in Drosophila. In 
addition, in the locust and C. elegans, the specific cellular mechanism mediating this 
regulation had not been elucidated. In Drosophila, food-deprivation is known to induce 
faster crawling and synaptic changes at the functional level (Steinert et al., 2006). 
Increased locomotor activity during food deprivation is sufficient to induce larger quantal 
sizes and enhanced evoked synaptic transmission at the larval NMJ. Yet, the 
involvement of octopamine was not examined. The work described in this thesis, for the 
first time, demonstrated real-time structural changes in neurons mediated by starvation 
and octopamine. 
 
Unveiling the mechanisms of aminergic synaptic growth 
To date, our understanding of the development and plasticity of aminergic 
terminals is meager – not only in Drosophila, but in other organisms as well. Given the 
vast literature on aminergic control of plasticity, it is hard to believe that few have 
investigated the development of the aminergic neurons themselves. In the second 
chapter of this dissertation, we have discovered an autoregulatory mechanism in 
octopaminergic neurons. The existence of octopamine autoreceptors was previously 
suggested in locusts. Yet, the receptor was not identified (Howell and Evans, 1998). 
This work has identified Octß1R and Octß2R as autoreceptors for octopamine, and both 
receptors are important for normal synaptic and behavioral plasticity.  
We also made the surprising finding that type II motorneurons require electrical 
activity for establishing primary innervation. Such severe effect of activity deprivation on 
neuronal structure is unusual, as it was thought that neurons devoid of activity can still 
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form their initial terminals (Aamodt and Constantine-Paton, 1999). Our finding is in 
contrast to the widely held view that activity is only necessary for refinement of existing 
synapses but not required for synaptogenesis. Our study raises the possibility that the 
development of modulatory aminergic terminals could have major differences from 
arbors that mediate classical neurotransmission. 
 
A possible explanation for an apparent controversy over the effect of octopamine 
at the Drosophila larval NMJ 
The role of octopamine at the Drosophila larval NMJ has been investigated in 
three studies. Two previous studies from the same group found that perfusion of 
octopamine results in an increase of excitatory junctional potential (Kutsukake et al., 
2000; Nagaya et al., 2002) while another study found the effect of octopamine to be 
inhibitory (Nishikawa and Kidokoro, 1999). In the second chapter of this dissertation, we 
showed that octopamine increases the amplitude of glutamatergic excitatory junctional 
potentials, supporting the results of the two former studies (Fig. 2-1J). We found this 
excitatory effect to be dependent on Octß2R, as bath application of octopamine to 
octß2R mutants did not change EJP amplitude as observed in wild type (data shown in 
text, page 45 last paragraph – page 46 first paragraph). In the third chapter, we 
identified an inhibitory octopamine receptor, Octß1R, that pairs with inhibitory G-protein 
Goα. This supports the latter study noted above of octopamine-induced inhibition. The 
work in this thesis suggests that the resulting excitatory or inhibitory effect of octopamine 
is likely dependent on the expression levels, affinity and availability of these receptors 
on the target cells. Since the conflicting studies mentioned above recorded from different 
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muscles at different larval stages, one possible explanation for the apparent discrepancy 
is the expression of different octopamine receptors in different muscles and/or neurons 
at different larval stages. 
 
Possible ways of cAMP modulation using both excitatory and inhibitory 
octopamine receptors simultaneously 
How could Octß1R and Octß2R control cAMP levels in opposite ways, given the 
assumption that they are expressed by the same cell and receive the same ligand? 
While currently we cannot fully resolve this question, a few different hypotheses based 
on the knowledge about G-protein-coupled receptors can be proposed. For example, if 
Octß1R and Octß2R have different affinities for octopamine binding, they could be 
activated by different concentrations of octopamine, resulting in differential cellular 
responses, depending on the strength of the stimulus. Indeed, it has been shown that in 
honeybees and olive fruit flies, low concentrations of octopamine are inhibitory while 
high concentrations are excitatory to cardiac contraction (Papaefthimiou et al., 2010). In 
another study, it was shown that 10 nM octopamine is sufficient to induce a significant 
Ca2+ increase mediated by OAMB, but it takes at least 50 nM octopamine to induce 
cAMP changes mediated by Octß1R (Balfanz et al., 2005). These studies strongly 
suggest that different octopamine receptors could have different affinities for 
octopamine. 
An alternative possibility is based on the observation that internalization of 
GPCRs after ligand-binding is a common phenomenon (Calebiro et al., 2010). For 
example, it has been shown that ß2-adrenergic receptors can undergo clathrin-mediated 
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endocytosis upon activation by its ligands (Gagnon et al., 1998). It is very likely that this 
mechanism would play a role in maintaining an appropriate ratio of octopamine 
receptors at the cell surface, actively keeping or removing octopamine receptor 
mediated excitation or inhibition, depending of physiological states.  
A third alternative is that receptors could be post-translationally modified upon 
ligand binding, which might also affect their downstream functions. For example, it has 
been demonstrated that dimerization of ß2-adrenergic receptors can inhibit its adenylate 
cyclase activating activity (Hebert et al., 1996). On the other hand, phosphorylation of 
ß2-adrenergic receptors by PKA reduces the affinity for Gs and increases the affinity for 
Gi/o (Martin et al., 2004).  
Lastly, the localization of Octß1R and Octß2R could be physically separated in 
neurons. One receptor could be localized closer to the site of octopamine release. 
Therefore, even receptors of the same affinity may experience different concentrations 
of octopamine simultaneously. In any case, the presence of both excitatory and 
inhibitory octopamine receptors in Drosophila has opened up many different possibilities 
for octopamine to modulate cellular cAMP levels. 
The coexpression of both excitatory and inhibitory GPCR is not a unique 
phenomenon in our system. For instance, mammalian dopamine receptors can also 
couple to both stimulatory and inhibitory G-proteins. The D1 receptor-like family is 
coupled to Gs, whereas the D2-like family is coupled to Gi/o (Beaulieu and Gainetdinov 
2011). It is not uncommon for GPCRs receiving the same ligand to activate different 
signaling pathways. In fact, dopamine autoreceptors have also been identified (Bello et 
al., 2011). However, so far only the inhibitory D2 receptors have been found to be an 
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autoreceptor (Bello et al., 2011), whereas we have demonstrated the presence of both 
excitatory and inhibitory octopamine autoreceptors in our study. 
 
Universality of CREB-mediated synaptic plasticity 
 CREB is a transcription factor involved in multiple forms of long-term synaptic 
plasticity, including late LTP and long-term memory. The macromolecular synthesis 
underlying long-term memory formation requires CREB-dependent transcription. Its 
function on mediating the transcription of synaptic effector proteins is conserved in both 
vertebrates and invertebrates (Benito and Barco, 2010). In adult Drosophila, long-term 
appetitive memory is CREB-dependent (Krashes et al., 2008). In C. elegans, 
octopamine receptors activate CREB signaling during food-deprivation (Suo et al., 
2006). Now, at the Drosophila larval NMJ, we demonstrated that the structural changes 
mediated by the autoregulatory mechanism in type II motorneurons require CREB. 
Remarkably, there seems to be great universality of mechanisms utilized by the neurons 
of different organisms to increase long-term synaptic strength using biogenic amines. It 
is certainly in our interest to examine what genes are being actively regulated by CREB, 
and which of these genes contributes to synaptopod formation. From our work in 
chapter 2, we have found numerous synaptic proteins that are present in synaptopods 
and pods-related structures (Fig. 2-2). However, since CREB may not directly regulate 
the transcription of these synaptic proteins, experiments like chromatin 
immunoprecipitation may be difficult.  
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Octopamine’s function may be more complex than simply signaling sugar 
reinforcement in classical conditioning of Drosophila 
The aversive memory paradigm requires five sessions of training to induce long-
term memory (Tully et al., 1994). In contrast, the appetitive memory paradigm induces 
long-term memory with a single session of training (Krashes et al., 2008). Remarkably, 
the appetitive paradigm requires octopamine and starvation of flies prior to the assay, 
and tbh mutants are defective in this type of conditioning (Schwaerzel et al., 2003). It 
has been proposed that octopamine functions to reinforce the sugar rewards in the 
appetitive memory paradigm (Hammer and Menzel, 1998; Schwaerzel et al., 2003). Our 
work demonstrated that the presence of octopamine reduced the requirement for activity 
to induce structural plasticity (Fig. 2-3), raising the possibility that octopamine may also 
function to modulate synaptic structures during appetitive conditioning.  
 
Presynaptic synaptopod-like structures are present in the CNS and may 
contribute to synaptogenesis 
 One question is whether synaptopod-like structures are only present at the NMJ. 
To address this question, we searched for presynaptic filopodia-like structures in the 
CNS in animals expressing mCD8-GFP using Tdc2-Gal4. We observed en passant 
boutons in both the ventral ganglion and the brain lobes (Fig. 4-1A,B). These en 
passant boutons contain TBH at their terminals, indicating they are axonal. To our 
excitement, synaptopod-like structures were found near these en passant boutons (Fig. 
4-1C). Furthermore, another Gal4 line, Ap-Gal4 (Calleja et al., 1996. Gift from Dr. John 
Thomas), which labels interneurons, also shows very dynamic filopodia-like structures in 
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the ventral ganglion. We were able to capture this kind of dynamic morphological 
plasticity in a living larval preparation without any kind of stimulation (Fig. 4-2). These 
data suggest to us that synaptopod-like filopodia could be very commonly found 
throughout the CNS, and that the effect of octopamine on synaptopods we examined in 
this study may not be limited to just the NMJ.  
 Unlike postsynaptic filopodia, which are widely considered the precursor of 
dendritic spines and contribute to activity-dependent synaptogenesis (Dailey and Smith, 
1996; Ziv and Smith, 1996; Fiala et al., 1998), the role of presynaptic filopodia-like 
structures is relatively unclear. Very few studies have shown that presynaptic filopodia-
like structures contribute to synaptogenesis (Nikonenko et al., 2003). Our work clearly 
indicates that synaptopods contribute to synapse formation at the NMJ, and we 
speculate that similar processes may also occur in the CNS. 
 
A model for octopaminergic control of synaptic and behavioral plasticity: working 
hypotheses and speculations 
Based on the work detailed in the previous chapters of this thesis and the currently 
available literature, I propose the following working model for octopaminergic signaling 
in regulating synaptic and behavioral plasticity in the Drosophila larva. Future 
experiments will be required, however, to support some of the speculations. 
In the Drosophila embryo, synaptogenesis by glutamatergic type I motorneurons on 
the body wall muscles does not require activity (Aamodt and Constantine-Paton, 1999). 
In contrast, octopaminergic type II innervation of the body wall is completely dependent 
on activity (Fig. 2-4). TBH is highly abundant in type II boutons (Fig. S2-3), presumably 
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to synthesize octopamine at the sites of release. Once the initial type II connections are 
established at the body wall muscles, the basal level of activity in type II is likely to 
facilitate octopamine secretion from matured type II boutons. This basal level of 
octopamine is required during development for normal synaptic growth of both type I 
and type II (Fig. 2-1, 2-6, 2-7). This is mostly mediated by octopamine receptor Octß2R 
which is present in both type I and type II (Fig. 2-6), and presumably activates the cAMP 
pathway via Gs proteins. But when food is not available, starvation of the larva will 
induce more activity in octopamine neurons, which will release more octopamine. The 
autoregulatory control of synaptic growth by Octß2R leads to continuous amplification of 
synaptic growth and synaptic strength. This leads to an increase in locomotor activity in 
order to forage for food. However, once food is encountered, this positive feedback 
mechanism needs to be turned off. This could be accomplished via the inhibitory Go-
coupled Octß1R receptors, which function as a brake for the continuous excitation. 
 
Critique of the current model and future directions 
 Despite the fact that we have a fairly comprehensive model that fits well with our 
data, there are still numerous parts of the model that could be further tested or refined. 
For instance, all our manipulations of type II motorneurons are currently performed using 
Tdc2-Gal4. However, this Gal4 is not only expressed in type II motorneurons 
exclusively, but is also expressed widely in the brain lobes as well. The fact that we 
manipulated all octopaminergic neurons in the CNS in all our experiments is a concern. 
It raises the question whether our observations of neuronal morphological changes and 
larval behavioral changes were really due to type II terminals or some other 
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octopaminergic cells in the CNS. One may argue that our manipulation could affect 
appetitive responses that relate to food-seeking and thus locomotion. Fortunately, since 
all the morphological changes we observed are at the NMJ, and since the type II 
terminals are the closest terminals that release octopamine (whereas octopamine from 
the CNS will have to travel across the blood brain barrier), it is more likely that the NMJs 
are modulated by the type II octopaminergic terminals instead of the ones in the CNS. In 
addition, our electrophysiology data have demonstrated that even without input from the 
CNS, octopamine can still affect EJPs at the NMJ. Therefore, even though we cannot 
exclude the involvement of the CNS in regulating larval movement speed during 
starvation, our data indicate that the octopamine from type II motorneurons alone is 
sufficient to increase movement speed. Nevertheless, it would be ideal if another type II 
Gal4 line without CNS expression could be used to reproduce the data in this thesis. 
That would add an extra level of confidence to our claim of the functions of type II 
motorneurons.  
 In our studies, we noticed a very interesting correlation between the increase of 
synaptopods in response to octopamine and the percentage increase of larval locomotor 
speed during starvation. In all the genotypes that we have examined (including all the 
mutants and all the genetically rescued animals), all of them demonstrated this 
correlation. Animals that showed a slight defect in octopamine-induced synaptopod 
increase showed a slight defective in starvation-induced locomotor increase, whereas 
animals that showed a strong defect in one showed a strongly defect in the other. 
However, currently we are not able to determine its significance, nor do we know if there 
is a causal relationship between the two. One experiment that could be done is 
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expressing Kir2.1 in muscles to suppress muscle depolarization using the Gal4 system 
while expressing ChR2 in type II motorneurons to acutely increase activity using the 
LexA system. We could then access whether the increase of synaptopods could still 
occur without involvement of locomotor activity or muscle contraction. 
Other experiments that can be performed in the future include the re-feeding of 
Drosophila larva after starvation to investigate if the increase of synaptopods is 
reversible when octopamine levels are lowered. However, we are aware that in other 
insects, like the locust, the effect of octopamine can persist for hours even after re-
feeding (Davenport and Evans, 1984).  
An important question that is currently unanswered is the localization of Octß1R 
and Octß2R in motorneurons. Since we had great difficulties raising antibodies against 
Octß1R and Octß2R and overexpression of these receptors appears to be a problematic 
method, we may attempt to tag these receptors using the recombineering technique in 
the future. This would allow us to analyze the localization of these tagged receptors 
expressed at endogenous level. 
Another experiment of interest would be to investigate the affinity of Octß1R and 
Octß2R by expressing these receptors in Drosophila S2 cell culture and monitoring 
cAMP changes in response to octopamine. This experiment would tell us whether these 
receptors are activated by different concentrations of octopamine, and would also test 
their antagonistic actions on cAMP. However, this experiment does face the same 
problem of other octopamine receptor overexpression studies, which is potentially 
inducing unnatural coupling to Gsα. Nevertheless, it is possible that lower expression 
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levels of receptors may circumvent this problem. Also, prior to the experiment, it would 
be necessary to verify the expression level of both Gsα and Goα in S2 cells. 
Last but not least, it would be very interesting to monitor real-time cAMP levels in 
live-preparations or intact animals using Epac-camps, a genetically encoded cAMP 
FRET sensor (Shafer et al., 2008). This would allow us to measure cAMP levels in our 
receptor mutants and allow us to examine cAMP changes in these animals in response 
to octopamine.  
  
Conclusion 
In conclusion, my thesis research has uncovered a number of mechanisms by 
which octopamine modulates synaptic and behavior plasticity. It is likely that the analysis 
of the other Drosophila octopamine receptors would further elucidate the complex 
control of plasticity by octopamine, and provide important implications to other biological 
processes, systems and organisms.  
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Figure 4-1 
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Figure 4-1. Synaptopod-like structures are not limited to the NMJ. Brain lobe of a fixed 
third instar larval preparation. mCD8-GFP is being expressed in octopaminergic neurons 
using Tdc2-Gal4. Labeled with anti-GFP and anti-HRP. (A) A section of approximately 
15 µm of the brain lobe. Octopaminergic neurons form en passant boutons containing 
TBH. (B) A sub-section of (A) of approximately 6 µm. (C) High magnification view of (B) 
showing synaptopod-like structures near octopaminergic terminals in the CNS. 
Calibration bar is 4 µm for A, B, and 1.7 µm for C. 
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                                Figure 4-2 
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Figure 4-2. Dynamic filopodia-like structures are not limited to octopaminergic neurons. 
Ventral ganglion of an unstimulated third instar living larval preparation. mCD8-GFP is 
being expressed in interneurons using Ap-Gal4. The filopodia-like structure indicated by 
the white arrow on the right extended over 3 µm within 1.5 minutes. Movie length was 1 
min 30 sec. Calibration bar is 3.5µm 
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